<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28638350</article-id><article-id pub-id-type="pmc">5461297</article-id><article-id pub-id-type="doi">10.3389/fphys.2017.00390</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Branched-Chain Amino Acid Ingestion Stimulates Muscle Myofibrillar Protein Synthesis following Resistance Exercise in Humans</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jackman</surname><given-names>Sarah R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/423199/overview"></uri></contrib><contrib contrib-type="author"><name><surname>Witard</surname><given-names>Oliver C.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/429867/overview"></uri></contrib><contrib contrib-type="author"><name><surname>Philp</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/211052/overview"></uri></contrib><contrib contrib-type="author"><name><surname>Wallis</surname><given-names>Gareth A.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/430004/overview"></uri></contrib><contrib contrib-type="author"><name><surname>Baar</surname><given-names>Keith</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/36824/overview"></uri></contrib><contrib contrib-type="author"><name><surname>Tipton</surname><given-names>Kevin D.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/423263/overview"></uri></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Sport and Health Sciences, College of Life and Environmental Sciences, University of Exeter</institution><country>Exeter, United Kingdom</country></aff><aff id="aff2"><sup>2</sup><institution>Physiology, Exercise and Nutrition Research Group, University of Stirling</institution><country>Stirling, United Kingdom</country></aff><aff id="aff3"><sup>3</sup><institution>School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham</institution><country>Birmingham, United Kingdom</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Neurobiology, Physiology and Behavior, University of California, Davis</institution><country>Davis, CA, United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Giuseppe D'Antona, University of Pavia, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Eva Blomstrand, The Swedish School of Sport and Health Sciences, Sweden; Vandre Casagrande Figueiredo, University of Auckland, New Zealand</p></fn><corresp id="fn001">*Correspondence: Sarah R. Jackman <email xlink:type="simple">s.jackman@exeter.ac.uk</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Exercise Physiology, a section of the journal Frontiers in Physiology</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>390</elocation-id><history><date date-type="received"><day>14</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>24</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>Copyright © 2017 Jackman, Witard, Philp, Wallis, Baar and Tipton.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Jackman, Witard, Philp, Wallis, Baar and Tipton</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><offsets xml_i="5255" xml_f="5987" txt_i="11" txt_f="743">The ingestion of intact protein or essential amino acids (EAA) stimulates mechanistic target of rapamycin complex-1 (mTORC1) signaling and muscle protein synthesis (MPS) following resistance exercise. The purpose of this study was to investigate the response of myofibrillar-MPS to ingestion of branched-chain amino acids (BCAAs) only (i.e., without concurrent ingestion of other EAA, intact protein, or other macronutrients) following resistance exercise in humans. Ten young (20.1 ± 1.3 years), resistance-trained men completed two trials, ingesting either 5.6 g BCAA or a placebo (PLA) drink immediately after resistance exercise. Myofibrillar-MPS was measured during exercise recovery with a primed, constant infusion of L-[ring</offsets><sup><offsets xml_i="5992" xml_f="5994" txt_i="743" txt_f="745">13</offsets></sup><offsets xml_i="6000" xml_f="6001" txt_i="745" txt_f="746">C</offsets><sub><offsets xml_i="6006" xml_f="6007" txt_i="746" txt_f="747">6</offsets></sub><offsets xml_i="6013" xml_f="6523" txt_i="747" txt_f="1257">] phenylalanine and collection of muscle biopsies pre and 4 h-post drink ingestion. Blood samples were collected at time-points before and after drink ingestion. Western blotting was used to measure the phosphorylation status of mTORC1 signaling proteins in biopsies collected pre, 1-, and 4 h-post drink. The percentage increase from baseline in plasma leucine (300 ± 96%), isoleucine (300 ± 88%), and valine (144 ± 59%) concentrations peaked 0.5 h-post drink in BCAA. A greater phosphorylation status of S6K1</offsets><sup><offsets xml_i="6528" xml_f="6534" txt_i="1257" txt_f="1263">Thr389</offsets></sup><offsets xml_i="6540" xml_f="6542" txt_i="1263" txt_f="1265"> (</offsets><italic><offsets xml_i="6550" xml_f="6551" txt_i="1265" txt_f="1266">P</offsets></italic><offsets xml_i="6560" xml_f="6582" txt_i="1266" txt_f="1288"> = 0.017) and PRAS40 (</offsets><italic><offsets xml_i="6590" xml_f="6591" txt_i="1288" txt_f="1289">P</offsets></italic><offsets xml_i="6600" xml_f="6702" txt_i="1289" txt_f="1391"> = 0.037) was observed in BCAA than PLA at 1 h-post drink ingestion. Myofibrillar-MPS was 22% higher (</offsets><italic><offsets xml_i="6710" xml_f="6711" txt_i="1391" txt_f="1392">P</offsets></italic><offsets xml_i="6720" xml_f="6848" txt_i="1392" txt_f="1520"> = 0.012) in BCAA (0.110 ± 0.009%/h) than PLA (0.090 ± 0.006%/h). Phenylalanine Ra was ~6% lower in BCAA (18.00 ± 4.31 μmol·kgBM</offsets><sup><offsets xml_i="6853" xml_f="6855" txt_i="1520" txt_f="1522">−1</offsets></sup><offsets xml_i="6861" xml_f="6895" txt_i="1522" txt_f="1556">) than PLA (21.75 ± 4.89 μmol·kgBM</offsets><sup><offsets xml_i="6900" xml_f="6902" txt_i="1556" txt_f="1558">−1</offsets></sup><offsets xml_i="6908" xml_f="6910" txt_i="1558" txt_f="1560">; </offsets><italic><offsets xml_i="6918" xml_f="6919" txt_i="1560" txt_f="1561">P</offsets></italic><offsets xml_i="6928" xml_f="7104" txt_i="1561" txt_f="1737"> = 0.028) after drink ingestion. We conclude that ingesting BCAAs alone increases the post-exercise stimulation of myofibrillar-MPS and phosphorylation status mTORC1 signaling.</offsets></p></abstract><kwd-group><kwd>amino acid ingestion</kwd><kwd>fractional synthesis rate</kwd><kwd>intracellular signaling proteins</kwd><kwd>leucine</kwd><kwd>muscle anabolism</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">GlaxoSmithKline<named-content content-type="fundref-id">10.13039/100004330</named-content></funding-source></award-group></funding-group><counts><fig-count count="6"></fig-count><table-count count="1"></table-count><equation-count count="3"></equation-count><ref-count count="47"></ref-count><page-count count="12"></page-count><word-count count="8527"></word-count></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title><offsets xml_i="7793" xml_f="7805" txt_i="1745" txt_f="1757">Introduction</offsets></title><p><offsets xml_i="7816" xml_f="8005" txt_i="1758" txt_f="1947">It is well-established that ingestion of essential amino acids (EAA) following resistance exercise stimulates an increased response of muscle protein synthesis MPS in humans (Smith et al., </offsets><xref rid="B36" ref-type="bibr"><offsets xml_i="8037" xml_f="8041" txt_i="1947" txt_f="1951">1998</offsets></xref><offsets xml_i="8048" xml_f="8065" txt_i="1951" txt_f="1968">; Tipton et al., </offsets><xref rid="B39" ref-type="bibr"><offsets xml_i="8097" xml_f="8102" txt_i="1968" txt_f="1973">1999a</offsets></xref><offsets xml_i="8109" xml_f="8284" txt_i="1973" txt_f="2148">). Indeed, the stimulation of MPS in humans can be achieved by supplying EAA only (i.e., the non-EAAs necessary for MPS may be supplied by endogenous sources) (Tipton et al., </offsets><xref rid="B41" ref-type="bibr"><offsets xml_i="8316" xml_f="8321" txt_i="2148" txt_f="2153">1999b</offsets></xref><offsets xml_i="8328" xml_f="8534" txt_i="2153" txt_f="2359">). More recent evidence from studies in rodents and cell culture models suggest that the stimulation of MPS by EAA may be mediated by a few amino acids rather than a combination of all EAA (Crozier et al., </offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="8566" xml_f="8570" txt_i="2359" txt_f="2363">2005</offsets></xref><offsets xml_i="8577" xml_f="8602" txt_i="2363" txt_f="2388">; Kimball and Jefferson, </offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="8634" xml_f="8638" txt_i="2388" txt_f="2392">2006</offsets></xref><offsets xml_i="8645" xml_f="8775" txt_i="2392" txt_f="2522">). The branched-chain amino acid (BCAA), leucine, has been shown to play a unique role in stimulating MPS (Kimball and Jefferson, </offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="8807" xml_f="8811" txt_i="2522" txt_f="2526">2006</offsets></xref><offsets xml_i="8818" xml_f="8988" txt_i="2526" txt_f="2696">). Leucine serves as substrate for the synthesis of new muscle proteins and as a signal to initiate the rate-limiting translation initiation step of MPS (Crozier et al., </offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="9020" xml_f="9024" txt_i="2696" txt_f="2700">2005</offsets></xref><offsets xml_i="9031" xml_f="9194" txt_i="2700" txt_f="2863">). Accordingly, the response of MPS to leucine provision has been extensively investigated over the past two decades, both in cell culture studies (Buse and Reid, </offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="9225" xml_f="9229" txt_i="2863" txt_f="2867">1975</offsets></xref><offsets xml_i="9236" xml_f="9261" txt_i="2867" txt_f="2892">; Kimball and Jefferson, </offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="9293" xml_f="9297" txt_i="2892" txt_f="2896">2006</offsets></xref><offsets xml_i="9304" xml_f="9323" txt_i="2896" txt_f="2915">; Atherton et al., </offsets><xref rid="B5" ref-type="bibr"><offsets xml_i="9354" xml_f="9359" txt_i="2915" txt_f="2920">2010b</offsets></xref><offsets xml_i="9366" xml_f="9372" txt_i="2920" txt_f="2926">) and </offsets><italic><offsets xml_i="9380" xml_f="9387" txt_i="2926" txt_f="2933">in vivo</offsets></italic><offsets xml_i="9396" xml_f="9421" txt_i="2933" txt_f="2958"> rodent (Anthony et al., </offsets><xref rid="B2" ref-type="bibr"><offsets xml_i="9452" xml_f="9456" txt_i="2958" txt_f="2962">1999</offsets></xref><offsets xml_i="9463" xml_f="9465" txt_i="2962" txt_f="2964">, </offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="9496" xml_f="9500" txt_i="2964" txt_f="2968">2000</offsets></xref><offsets xml_i="9507" xml_f="9525" txt_i="2968" txt_f="2986">; Crozier et al., </offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="9557" xml_f="9561" txt_i="2986" txt_f="2990">2005</offsets></xref><offsets xml_i="9568" xml_f="9585" txt_i="2990" txt_f="3007">; Norton et al., </offsets><xref rid="B33" ref-type="bibr"><offsets xml_i="9617" xml_f="9621" txt_i="3007" txt_f="3011">2012</offsets></xref><offsets xml_i="9628" xml_f="9651" txt_i="3011" txt_f="3034">) and human (Matthews, </offsets><xref rid="B26" ref-type="bibr"><offsets xml_i="9683" xml_f="9687" txt_i="3034" txt_f="3038">2005</offsets></xref><offsets xml_i="9694" xml_f="9714" txt_i="3038" txt_f="3058">; Wilkinson et al., </offsets><xref rid="B45" ref-type="bibr"><offsets xml_i="9746" xml_f="9750" txt_i="3058" txt_f="3062">2013</offsets></xref><offsets xml_i="9757" xml_f="9767" txt_i="3062" txt_f="3072">) studies.</offsets></p><p><offsets xml_i="9774" xml_f="9938" txt_i="3073" txt_f="3237">The stimulation of MPS is accompanied by an increased activation of intracellular signaling proteins that regulate the translational activity of MPS (Philp et al., </offsets><xref rid="B35" ref-type="bibr"><offsets xml_i="9970" xml_f="9974" txt_i="3237" txt_f="3241">2011</offsets></xref><offsets xml_i="9981" xml_f="10250" txt_i="3241" txt_f="3510">). In particular, the mechanistic/mammalian target of rapamycin complex-1 (mTORC1) signaling, often assessed as the phosphorylation status of the 70 kDa ribosomal S6 protein kinase (S6K1), is stimulated by ingestion of EAA following resistance exercise (Dreyer et al., </offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="10282" xml_f="10286" txt_i="3510" txt_f="3514">2008</offsets></xref><offsets xml_i="10293" xml_f="10310" txt_i="3514" txt_f="3531">; Moberg et al., </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="10342" xml_f="10346" txt_i="3531" txt_f="3535">2016</offsets></xref><offsets xml_i="10353" xml_f="10433" txt_i="3535" txt_f="3615">). There is current debate over whether leucine alone (Churchward-Venne et al., </offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="10465" xml_f="10469" txt_i="3615" txt_f="3619">2014</offsets></xref><offsets xml_i="10476" xml_f="10517" txt_i="3619" txt_f="3660">), or the BCAAs combined (Moberg et al., </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="10549" xml_f="10553" txt_i="3660" txt_f="3664">2016</offsets></xref><offsets xml_i="10560" xml_f="10788" txt_i="3664" txt_f="3892">), provide the most important component of an exogenous EAA source for stimulating the mTORC1-S6K1 signaling pathway. Whereas, the inclusion of leucine is necessary for the maximal activation of mTORC1 signaling (Moberg et al., </offsets><xref rid="B30" ref-type="bibr"><offsets xml_i="10820" xml_f="10824" txt_i="3892" txt_f="3896">2014</offsets></xref><offsets xml_i="10831" xml_f="10997" txt_i="3896" txt_f="4062">), recent results from the same research group show that mTORC1 signaling is enhanced with the addition of the other two BCAAs, valine and isoleucine (Moberg et al., </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="11029" xml_f="11033" txt_i="4062" txt_f="4066">2016</offsets></xref><offsets xml_i="11040" xml_f="11146" txt_i="4066" txt_f="4172">). Moreover, there often is a disconnect between the response of mTORC1 signaling and MPS (Witard et al., </offsets><xref rid="B47" ref-type="bibr"><offsets xml_i="11178" xml_f="11182" txt_i="4172" txt_f="4176">2009</offsets></xref><offsets xml_i="11189" xml_f="11208" txt_i="4176" txt_f="4195">; Atherton et al., </offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="11239" xml_f="11244" txt_i="4195" txt_f="4200">2010a</offsets></xref><offsets xml_i="11251" xml_f="11267" txt_i="4200" txt_f="4216">; Glynn et al., </offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="11299" xml_f="11303" txt_i="4216" txt_f="4220">2010</offsets></xref><offsets xml_i="11310" xml_f="11332" txt_i="4220" txt_f="4242">; Macnaughton et al., </offsets><xref rid="B25" ref-type="bibr"><offsets xml_i="11364" xml_f="11368" txt_i="4242" txt_f="4246">2016</offsets></xref><offsets xml_i="11375" xml_f="11393" txt_i="4246" txt_f="4264">; McGlory et al., </offsets><xref rid="B28" ref-type="bibr"><offsets xml_i="11425" xml_f="11429" txt_i="4264" txt_f="4268">2016</offsets></xref><offsets xml_i="11436" xml_f="11502" txt_i="4268" txt_f="4334">). Thus, the response of MPS to BCAA ingestion is still uncertain.</offsets></p><p><offsets xml_i="11509" xml_f="11635" txt_i="4335" txt_f="4461">In humans, the ingestion of leucine alone has been shown to stimulate an increased response of MPS at rest (Wilkinson et al., </offsets><xref rid="B45" ref-type="bibr"><offsets xml_i="11667" xml_f="11671" txt_i="4461" txt_f="4465">2013</offsets></xref><offsets xml_i="11678" xml_f="11896" txt_i="4465" txt_f="4683">). Moreover, enriching a “suboptimal” 6.25 g dose of intact protein with additional leucine has been shown to increase the response of MPS equivalent to an “optimal” 25 g protein dose at rest (Churchward-Venne et al., </offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="11928" xml_f="11932" txt_i="4683" txt_f="4687">2012</offsets></xref><offsets xml_i="11939" xml_f="12036" txt_i="4687" txt_f="4784">). However, studies investigating, the influence of leucine co-ingestion with EAA (Glynn et al., </offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="12068" xml_f="12072" txt_i="4784" txt_f="4788">2010</offsets></xref><offsets xml_i="12079" xml_f="12117" txt_i="4788" txt_f="4826">), or intact protein (Koopman et al., </offsets><xref rid="B22" ref-type="bibr"><offsets xml_i="12149" xml_f="12153" txt_i="4826" txt_f="4830">2005</offsets></xref><offsets xml_i="12160" xml_f="12162" txt_i="4830" txt_f="4832">, </offsets><xref rid="B21" ref-type="bibr"><offsets xml_i="12194" xml_f="12198" txt_i="4832" txt_f="4836">2006</offsets></xref><offsets xml_i="12205" xml_f="12207" txt_i="4836" txt_f="4838">, </offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="12239" xml_f="12243" txt_i="4838" txt_f="4842">2008</offsets></xref><offsets xml_i="12250" xml_f="12267" txt_i="4842" txt_f="4859">; Tipton et al., </offsets><xref rid="B38" ref-type="bibr"><offsets xml_i="12299" xml_f="12303" txt_i="4859" txt_f="4863">2009</offsets></xref><offsets xml_i="12310" xml_f="12325" txt_i="4863" txt_f="4878">; Wall et al., </offsets><xref rid="B44" ref-type="bibr"><offsets xml_i="12357" xml_f="12361" txt_i="4878" txt_f="4882">2013</offsets></xref><offsets xml_i="12368" xml_f="12553" txt_i="4882" txt_f="5067">) on the stimulation of MPS in young men report equivocal results. Whereas, the addition of leucine to whey protein failed to enhance the post-exercise response of MPS (Koopman et al., </offsets><xref rid="B22" ref-type="bibr"><offsets xml_i="12585" xml_f="12589" txt_i="5067" txt_f="5071">2005</offsets></xref><offsets xml_i="12596" xml_f="12598" txt_i="5071" txt_f="5073">, </offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="12630" xml_f="12634" txt_i="5073" txt_f="5077">2008</offsets></xref><offsets xml_i="12641" xml_f="12658" txt_i="5077" txt_f="5094">; Tipton et al., </offsets><xref rid="B38" ref-type="bibr"><offsets xml_i="12690" xml_f="12694" txt_i="5094" txt_f="5098">2009</offsets></xref><offsets xml_i="12701" xml_f="12826" txt_i="5098" txt_f="5223">), adding leucine to a casein protein source was shown to increase the resting postprandial stimulation of MPS (Wall et al., </offsets><xref rid="B44" ref-type="bibr"><offsets xml_i="12858" xml_f="12862" txt_i="5223" txt_f="5227">2013</offsets></xref><offsets xml_i="12869" xml_f="13256" txt_i="5227" txt_f="5614">). While the response of MPS to leucine provision, with or without an intact protein source, is well-characterized, to our knowledge no study has successfully determined the response of MPS to the independent ingestion all three BCAAs (leucine, isoleucine, and valine) combined (i.e., without concurrent ingestion of intact protein or other macronutrients) following resistance exercise.</offsets></p><p><offsets xml_i="13263" xml_f="13353" txt_i="5615" txt_f="5705">There is ample evidence that BCAA ingestion stimulates mTORC1 signaling (Karlsson et al., </offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="13385" xml_f="13389" txt_i="5705" txt_f="5709">2004</offsets></xref><offsets xml_i="13396" xml_f="13419" txt_i="5709" txt_f="5732">; Apro and Blomstrand, </offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="13450" xml_f="13454" txt_i="5732" txt_f="5736">2010</offsets></xref><offsets xml_i="13461" xml_f="13478" txt_i="5736" txt_f="5753">; Moberg et al., </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="13510" xml_f="13514" txt_i="5753" txt_f="5757">2016</offsets></xref><offsets xml_i="13521" xml_f="13894" txt_i="5757" txt_f="6130">), however the post-exercise response of MPS to BCAA ingestion remains unknown. A recent investigation with a similar design reported MPS data, but the very large variability in generated fractional synthetic rate (FSR) values precluded a solid conclusion from being drawn. Therefore, given uncertainty due to the known disconnect between signaling and MPS (Witard et al., </offsets><xref rid="B47" ref-type="bibr"><offsets xml_i="13926" xml_f="13930" txt_i="6130" txt_f="6134">2009</offsets></xref><offsets xml_i="13937" xml_f="13956" txt_i="6134" txt_f="6153">; Atherton et al., </offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="13987" xml_f="13992" txt_i="6153" txt_f="6158">2010a</offsets></xref><offsets xml_i="13999" xml_f="14083" txt_i="6158" txt_f="6242">) and previous methodological difficulties in other research groups (Moberg et al., </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="14115" xml_f="14119" txt_i="6242" txt_f="6246">2016</offsets></xref><offsets xml_i="14126" xml_f="14694" txt_i="6246" txt_f="6814">), the primary aim of the present study was to determine the response of myofibrillar-MPS to ingestion of a drink containing BCAAs, but no other EAA, protein, or macronutrients, following resistance exercise. In addition, we also measured the phosphorylation status (as a surrogate marker of activity) of proteins within the mTORC1 signaling pathway in response to BCAA ingestion. We hypothesized that BCAA ingestion would increase both the stimulation of myofibrillar-MPS and the phosphorylation status of mTORC1-S6K1 signaling proteins following resistance exercise.</offsets></p></sec><sec sec-type="materials and methods" id="s2"><title><offsets xml_i="14757" xml_f="14778" txt_i="6816" txt_f="6837">Materials and methods</offsets></title><sec><title><offsets xml_i="14798" xml_f="14830" txt_i="6838" txt_f="6870">Participants and ethics approval</offsets></title><p><offsets xml_i="14841" xml_f="15088" txt_i="6871" txt_f="7115">Eleven healthy (body mass: 83.3 ± 11.7 kg; percent lean mass: 86.1 ± 4.1%) young (20.1 ± 1.3 years) men who regularly participated in resistance training of the lower body (≥2/week for &gt;1 years) volunteered to participate in the present study. </offsets><italic><offsets xml_i="15096" xml_f="15104" txt_i="7115" txt_f="7123">A priori</offsets></italic><offsets xml_i="15113" xml_f="15249" txt_i="7123" txt_f="7259">, we conducted a power calculation (GPower v3 software) of appropriate sample size based on our previous published data (Witard et al., </offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="15281" xml_f="15285" txt_i="7259" txt_f="7263">2014</offsets></xref><offsets xml_i="15292" xml_f="15620" txt_i="7263" txt_f="7591">) that measured, on average, a 37% higher post-exercise response of myofibrillar-MPS to 20 g of ingested whey protein compared with 0 g using the same tracer technique. The BCAA trial in the present study contained a similar quantity of BCAAs as the 20 g bolus of whey protein administered in our previous study (Witard et al., </offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="15652" xml_f="15656" txt_i="7591" txt_f="7595">2014</offsets></xref><offsets xml_i="15663" xml_f="15786" txt_i="7595" txt_f="7718">; 5.6 vs. 4.8 g). By setting statistical power (1-ß err prob) at 0.8, α error probability at 0.05 and effect size (Cohen's </offsets><italic><offsets xml_i="15794" xml_f="15795" txt_i="7718" txt_f="7719">d</offsets></italic><offsets xml_i="15804" xml_f="15857" txt_i="7719" txt_f="7772">) at 1.4 (based on our previous data; Witard et al., </offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="15889" xml_f="15893" txt_i="7772" txt_f="7776">2014</offsets></xref><offsets xml_i="15900" xml_f="16240" txt_i="7776" txt_f="8116">), our power calculation revealed a minimum sample size of 10 participants (using a crossover research design) would be necessary to detect a statistical difference in myofibrillar-MPS between BCAA and placebo trials. Due to illness, only 10 participants completed both experimental trials, therefore all data are shown for 10 participants.</offsets></p><p><offsets xml_i="16247" xml_f="17000" txt_i="8117" txt_f="8870">The design, purpose, and potential risks associated with the study were explained to participants before obtaining written informed consent. Exclusion criteria were metabolic disorders, food intolerances/allergies, allergies to local anesthetic, current participation in other clinical trials, blood donations within three months of the initial screening visit, and the prescription of medication or consumption of nutritional/dietary supplements suggested to affect protein metabolism. The National Research Ethics Service board (Warwickshire, Birmingham, UK) approved all procedures and all were in accordance with the Helsinki Declaration of 1975 as revised in 1983. This trial is registered as a clinical trial (registration number: ISRCTN98737111).</offsets></p></sec><sec><title><offsets xml_i="17022" xml_f="17041" txt_i="8872" txt_f="8891">Experimental design</offsets></title><p><offsets xml_i="17052" xml_f="17807" txt_i="8892" txt_f="9647">Participants reported to the laboratory on five separate occasions, including two experimental trials that were separated by approximately three weeks. During the initial visit, body composition was assessed using dual-energy x-ray absorptiometry (DEXA; Hologic Discovery W, Hologic Inc., Bedford, Massachusetts, USA) and one repetition maximum (1RM) was predicted for each leg individually on both leg press and leg extension. Approximately one week later, participants returned to the laboratory to confirm their 1RM for each leg. Three days later, participants performed their first blinded trial in which they consumed either a BCAA containing drink (BCAA; GlaxoSmithKline, Brentford, UK) or placebo (PLA) drink (GlaxoSmithKline, Brentford, UK; Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="17839" xml_f="17840" txt_i="9647" txt_f="9648">1</offsets></xref><offsets xml_i="17847" xml_f="18137" txt_i="9648" txt_f="9938">). BCAA contained 5.6 g of BCAAs which is equivalent to the typical BCAA content of 20 g whey protein. Participants performed a unilateral bout of resistance exercise prior to consuming the test drink in each trial. Myofibrillar-MPS was determined by measuring the incorporation of L-[ring-</offsets><sup><offsets xml_i="18142" xml_f="18144" txt_i="9938" txt_f="9940">13</offsets></sup><offsets xml_i="18150" xml_f="18151" txt_i="9940" txt_f="9941">C</offsets><sub><offsets xml_i="18156" xml_f="18157" txt_i="9941" txt_f="9942">6</offsets></sub><offsets xml_i="18163" xml_f="18427" txt_i="9942" txt_f="10206">] phenylalanine into myofibrillar protein during a primed continuous infusion. The complete testing procedure was repeated on the contralateral leg approximately three weeks after the first trial. Trial and exercised leg order were counter-balanced and randomized.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="18475" xml_f="18482" txt_i="10207" txt_f="10214">Table 1</offsets></label><caption><p><offsets xml_i="18502" xml_f="18536" txt_i="10214" txt_f="10248">Nutritional composition of drinks.</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><offsets xml_i="18693" xml_f="18696" txt_i="10249" txt_f="10252">PLA</offsets></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><offsets xml_i="18770" xml_f="18774" txt_i="10252" txt_f="10256">BCAA</offsets></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><offsets xml_i="18864" xml_f="18879" txt_i="10256" txt_f="10271">Calories (Kcal)</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="18940" xml_f="18942" txt_i="10272" txt_f="10274">13</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19003" xml_f="19005" txt_i="10275" txt_f="10277">13</offsets></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><offsets xml_i="19073" xml_f="19084" txt_i="10278" txt_f="10289">Leucine (g)</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19145" xml_f="19146" txt_i="10290" txt_f="10291">0</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19207" xml_f="19210" txt_i="10292" txt_f="10295">2.6</offsets></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><offsets xml_i="19278" xml_f="19292" txt_i="10296" txt_f="10310">Isoleucine (g)</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19353" xml_f="19354" txt_i="10311" txt_f="10312">0</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19415" xml_f="19418" txt_i="10313" txt_f="10316">1.4</offsets></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><offsets xml_i="19486" xml_f="19496" txt_i="10317" txt_f="10327">Valine (g)</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19557" xml_f="19558" txt_i="10328" txt_f="10329">0</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19619" xml_f="19622" txt_i="10330" txt_f="10333">1.6</offsets></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><offsets xml_i="19690" xml_f="19706" txt_i="10334" txt_f="10350">Carbohydrate (g)</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19767" xml_f="19770" txt_i="10351" txt_f="10354">4.6</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19831" xml_f="19834" txt_i="10355" txt_f="10358">3.1</offsets></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><offsets xml_i="19902" xml_f="19909" txt_i="10359" txt_f="10366">Fat (g)</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="19970" xml_f="19974" txt_i="10367" txt_f="10371">0.02</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="20035" xml_f="20039" txt_i="10372" txt_f="10376">0.01</offsets></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><offsets xml_i="20107" xml_f="20117" txt_i="10377" txt_f="10387">Sodium (g)</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="20178" xml_f="20181" txt_i="10388" txt_f="10391">0.2</offsets></td><td valign="top" align="center" rowspan="1" colspan="1"><offsets xml_i="20242" xml_f="20245" txt_i="10392" txt_f="10395">0.2</offsets></td></tr></tbody></table><table-wrap-foot><p><italic><offsets xml_i="20299" xml_f="20601" txt_i="10396" txt_f="10698">Drinks were consumed after a unilateral bout of resistance exercise and were either a branched-chain amino acid containing drink (BCAA) or a placebo (PLA) drink. BCAA contained 5.6 g of branched-chain amino acids which is equivalent to the typical branched-chain amino acid content of 20 g whey protein</offsets></italic><offsets xml_i="20610" xml_f="20611" txt_i="10698" txt_f="10699">.</offsets></p></table-wrap-foot></table-wrap></sec><sec><title><offsets xml_i="20664" xml_f="20683" txt_i="10701" txt_f="10720">Preliminary testing</offsets></title><sec><title><offsets xml_i="20703" xml_f="20720" txt_i="10721" txt_f="10738">Exercise sessions</offsets></title><p><offsets xml_i="20731" xml_f="20946" txt_i="10739" txt_f="10951">At least six days before and &lt;2 week prior to the first infusion trial, 1RM was predicted for both legs of each participant on the leg press and leg extension using a previously published method (Verdijk et al., </offsets><xref rid="B43" ref-type="bibr"><offsets xml_i="20978" xml_f="20982" txt_i="10951" txt_f="10955">2009</offsets></xref><offsets xml_i="20989" xml_f="21217" txt_i="10955" txt_f="11183">). Briefly, volunteers warmed up each leg before completing the maximum number of repetitions at 80% of predicted 1RM. This exercise load was then inserted into an equation as previously reported to estimate 1RM (Mayhew et al., </offsets><xref rid="B27" ref-type="bibr"><offsets xml_i="21249" xml_f="21253" txt_i="11183" txt_f="11187">1995</offsets></xref><offsets xml_i="21260" xml_f="21262" txt_i="11187" txt_f="11189">).</offsets></p><p><offsets xml_i="21269" xml_f="21408" txt_i="11190" txt_f="11329">Three days prior to both infusion trials, participants returned to the laboratory to confirm their 1RM on both exercises (Kraemer and Fry, </offsets><xref rid="B23" ref-type="bibr"><offsets xml_i="21440" xml_f="21444" txt_i="11329" txt_f="11333">1995</offsets></xref><offsets xml_i="21451" xml_f="21793" txt_i="11333" txt_f="11675">) on the leg that was to be exercised in the forthcoming trial. Briefly, the load was set to 90% of estimated 1RM from the previous session. Participants completed the maximum number of repetitions possible. The load was then increased by 5–10% until only one repetition could be completed. A rest period of 3 min was given between each load.</offsets></p></sec></sec><sec><title><offsets xml_i="21821" xml_f="21877" txt_i="11678" txt_f="11734">Body composition, dietary control, and physical activity</offsets></title><p><offsets xml_i="21888" xml_f="22240" txt_i="11735" txt_f="12087">During the initial visit, body composition (total and segmental) was assessed using DEXA. Prior the experimental trial, participants completed a questionnaire of food preferences and a 3-day diet diary that represented their habitual daily intakes. The average energy intake (3,392 ± 1,069 kcal) and macronutrient composition [protein: 2.2 ± 1.0 g·kgBM</offsets><sup><offsets xml_i="22245" xml_f="22247" txt_i="12087" txt_f="12089">−1</offsets></sup><offsets xml_i="22253" xml_f="22255" txt_i="12089" txt_f="12091">·d</offsets><sup><offsets xml_i="22260" xml_f="22262" txt_i="12091" txt_f="12093">−1</offsets></sup><offsets xml_i="22268" xml_f="22300" txt_i="12093" txt_f="12125">; carbohydrate: 4.7 ± 1.6 g·kgBM</offsets><sup><offsets xml_i="22305" xml_f="22307" txt_i="12125" txt_f="12127">−1</offsets></sup><offsets xml_i="22313" xml_f="22316" txt_i="12127" txt_f="12130"> ·d</offsets><sup><offsets xml_i="22321" xml_f="22323" txt_i="12130" txt_f="12132">−1</offsets></sup><offsets xml_i="22329" xml_f="22352" txt_i="12132" txt_f="12155">; fat: 1.4 ± 0.4 g·kgBM</offsets><sup><offsets xml_i="22357" xml_f="22359" txt_i="12155" txt_f="12157">−1</offsets></sup><offsets xml_i="22365" xml_f="22367" txt_i="12157" txt_f="12159">·d</offsets><sup><offsets xml_i="22372" xml_f="22374" txt_i="12159" txt_f="12161">−1</offsets></sup><offsets xml_i="22380" xml_f="23074" txt_i="12161" txt_f="12855">] from the 3 day diet diary was used to calculate the participant's diet before the experimental trial. Food parcels, which matched each participant's habitual energy and macronutrient intakes, were supplied for 48 h before the experimental trial. Participants were instructed to consume only food and drink sources provided by investigators and to consume their final meal no later than 22:00 on the evening before the experimental protocol. Analyses of the diet diary and food prescription were performed by using a commercially available software program (Wisp v3; Tinuviel software). All participants were instructed to refrain from physical exercise for 48 h before the experimental trial.</offsets></p></sec><sec><title><offsets xml_i="23096" xml_f="23117" txt_i="12857" txt_f="12878">Experimental protocol</offsets></title><p><offsets xml_i="23128" xml_f="23200" txt_i="12879" txt_f="12951">A schematic diagram of the experimental protocol is displayed in Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="23230" xml_f="23231" txt_i="12951" txt_f="12952">1</offsets></xref><offsets xml_i="23238" xml_f="23546" txt_i="12952" txt_f="13260">. Participants reported to the laboratory at ~06:15 following an overnight fast and measurements of height and weight were collected. A cannula was inserted into a forearm vein of one arm, and a resting blood sample was collected. Thereafter, participants were fed a standardized energy-rich (7 ± 1 kcal·kgBM</offsets><sup><offsets xml_i="23551" xml_f="23553" txt_i="13260" txt_f="13262">−1</offsets></sup><offsets xml_i="23559" xml_f="23753" txt_i="13262" txt_f="13456">), high protein (30 ± 1% of energy from protein, 50 ± 1% of energy from carbohydrate, and 20 ± 1% of energy from fat) breakfast. After breakfast a primed, continuous infusion (prime: ~88 μmol·kg</offsets><sup><offsets xml_i="23758" xml_f="23760" txt_i="13456" txt_f="13458">−1</offsets></sup><offsets xml_i="23766" xml_f="23799" txt_i="13458" txt_f="13491">; infusion rate: ~0.227 μmol·kgBM</offsets><sup><offsets xml_i="23804" xml_f="23806" txt_i="13491" txt_f="13493">−1</offsets></sup><offsets xml_i="23812" xml_f="23816" txt_i="13493" txt_f="13497">·min</offsets><sup><offsets xml_i="23821" xml_f="23823" txt_i="13497" txt_f="13499">−1</offsets></sup><offsets xml_i="23829" xml_f="23834" txt_i="13499" txt_f="13504">) of </offsets><sup><offsets xml_i="23839" xml_f="23841" txt_i="13504" txt_f="13506">15</offsets></sup><offsets xml_i="23847" xml_f="23848" txt_i="13506" txt_f="13507">N</offsets><sub><offsets xml_i="23853" xml_f="23854" txt_i="13507" txt_f="13508">2</offsets></sub><offsets xml_i="23860" xml_f="23985" txt_i="13508" txt_f="13633"> urea was started and continued throughout the protocol. Subjects rested for ~75 min before a primed, continuous (2.0 μmol·kg</offsets><sup><offsets xml_i="23990" xml_f="23992" txt_i="13633" txt_f="13635">−1</offsets></sup><offsets xml_i="23998" xml_f="24024" txt_i="13635" txt_f="13661">; infusion ~0.05 μmol·kgBM</offsets><sup><offsets xml_i="24029" xml_f="24031" txt_i="13661" txt_f="13663">−1</offsets></sup><offsets xml_i="24037" xml_f="24041" txt_i="13663" txt_f="13667">.min</offsets><sup><offsets xml_i="24046" xml_f="24048" txt_i="13667" txt_f="13669">−1</offsets></sup><offsets xml_i="24054" xml_f="24075" txt_i="13669" txt_f="13690">) infusion of L-ring </offsets><sup><offsets xml_i="24080" xml_f="24082" txt_i="13690" txt_f="13692">13</offsets></sup><offsets xml_i="24088" xml_f="24089" txt_i="13692" txt_f="13693">C</offsets><sub><offsets xml_i="24094" xml_f="24095" txt_i="13693" txt_f="13694">6</offsets></sub><offsets xml_i="24101" xml_f="24200" txt_i="13694" txt_f="13793"> phenylalanine (both Cambridge Isotope Laboratories Inc., Andover, Massachusetts, USA) was started.</offsets></p><fig id="F1" position="float"><label><offsets xml_i="24241" xml_f="24249" txt_i="13794" txt_f="13802">Figure 1</offsets></label><caption><p><offsets xml_i="24269" xml_f="24517" txt_i="13802" txt_f="14050">Schematic diagram of the infusion protocol. A baseline blood sample was collected before participants consumed an energy-rich, high-protein breakfast. A bout of unilateral leg-resistance exercise was performed 3 h after breakfast. Muscle biopsies (</offsets><italic><offsets xml_i="24525" xml_f="24541" txt_i="14050" txt_f="14066">vastus lateralis</offsets></italic><offsets xml_i="24550" xml_f="24824" txt_i="14066" txt_f="14340">) were collected from the exercised leg immediately prior (0 h), 1-, or 4 h-post drink ingestion. Drink ingestion was either a branched-chain amino acid containing beverage (BCAA) or placebo (PLA). Multiple blood samples were collected throughout the protocol. Ex, exercise.</offsets></p></caption><graphic xlink:href="fphys-08-00390-g0001"></graphic></fig><p><offsets xml_i="24900" xml_f="25652" txt_i="14341" txt_f="15093">Approximately 105 min later, participants performed a single bout of unilateral leg resistance exercise which lasted ~25 min. Participants completed a warm up on the leg press machine (Cybex VR3, Cybex International, Medway, Massachusetts, USA), which consisted of 12 repetitions at 40% 1RM, 10 repetitions at 50% 1RM, eight repetitions at 60% 1RM, and two repetitions at 70% 1RM. The warm up was followed by a 2 min rest period. The resistance exercise protocol consisted of four sets of 10 repetitions at 70% 1RM on the leg press machine and four sets of 10 repetitions at 75% 1RM on the leg extension machine (Cybex VR3, Cybex International, Medway, Massachusetts, USA). Participants rested for 2 min between each set and were free to consume water </offsets><italic><offsets xml_i="25660" xml_f="25670" txt_i="15093" txt_f="15103">ad libitum</offsets></italic><offsets xml_i="25679" xml_f="25833" txt_i="15103" txt_f="15257">. If a participant could not complete a full set, the load was lowered by 4.5 kg. Rating of perceived exertion (RPE) using the modified Borg scale (Borg, </offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="25864" xml_f="25868" txt_i="15257" txt_f="15261">1973</offsets></xref><offsets xml_i="25875" xml_f="25943" txt_i="15261" txt_f="15329">) was measured after each set. Immediately (~5 min) after exercise (</offsets><italic><offsets xml_i="25951" xml_f="25952" txt_i="15329" txt_f="15330">t</offsets></italic><offsets xml_i="25961" xml_f="26136" txt_i="15330" txt_f="15505"> = 0 min), an arterialized blood sample and a muscle biopsy were collected followed by ingestion of the test drink. Blood samples also were collected at multiple time points (</offsets><italic><offsets xml_i="26144" xml_f="26145" txt_i="15505" txt_f="15506">t</offsets></italic><offsets xml_i="26154" xml_f="26339" txt_i="15506" txt_f="15691"> = −240, −145, −85, −25, 0, 15, 30, 45, 60, 75, 90, 120, 150, 180, 240 min) before and after drink ingestion. Two further muscle biopsies were collected 1 and 4 h after drink ingestion.</offsets></p></sec><sec><title><offsets xml_i="26361" xml_f="26398" txt_i="15693" txt_f="15730">Muscle biopsy collection and analysis</offsets></title><p><offsets xml_i="26409" xml_f="26448" txt_i="15731" txt_f="15770">Muscle biopsies were obtained from the </offsets><italic><offsets xml_i="26456" xml_f="26472" txt_i="15770" txt_f="15786">vastus lateralis</offsets></italic><offsets xml_i="26481" xml_f="27042" txt_i="15786" txt_f="16347"> of the exercised leg under local anesthesia (1% lidocaine) using 5 mm Bergstrom needles with suction. Different incisions (~1 cm apart, proximally from previous site) were used for each biopsy in an attempt to minimize the impact of local inflammation from the previous biopsy sample. Biopsy samples were immediately rinsed, blotted of excess blood, removed of visible fat and connective tissue, and divided into aliquots, before being frozen in liquid nitrogen, and stored at –80°C until later analysis. Muscle samples were analyzed for enrichment of L-[ring-</offsets><sup><offsets xml_i="27047" xml_f="27049" txt_i="16347" txt_f="16349">13</offsets></sup><offsets xml_i="27055" xml_f="27056" txt_i="16349" txt_f="16350">C</offsets><sub><offsets xml_i="27061" xml_f="27062" txt_i="16350" txt_f="16351">6</offsets></sub><offsets xml_i="27068" xml_f="27260" txt_i="16351" txt_f="16543">] phenylalanine in the intracellular pool and bound myofibrillar protein fractions, Furthermore, muscle was analyzed to measure the phosphorylation status of mTORC1-related signaling proteins.</offsets></p></sec><sec><title><offsets xml_i="27282" xml_f="27313" txt_i="16545" txt_f="16576">Myofibrillar protein enrichment</offsets></title><p><offsets xml_i="27324" xml_f="27377" txt_i="16577" txt_f="16630">Muscle tissue was analyzed for enrichment of L-[ring-</offsets><sup><offsets xml_i="27382" xml_f="27384" txt_i="16630" txt_f="16632">13</offsets></sup><offsets xml_i="27390" xml_f="27391" txt_i="16632" txt_f="16633">C</offsets><sub><offsets xml_i="27396" xml_f="27397" txt_i="16633" txt_f="16634">6</offsets></sub><offsets xml_i="27403" xml_f="27551" txt_i="16634" txt_f="16782">] phenylalanine in the myofibrillar protein fraction. Myofibrillar proteins were isolated from ~30 mg tissue as previously described (Moore et al., </offsets><xref rid="B31" ref-type="bibr"><offsets xml_i="27583" xml_f="27587" txt_i="16782" txt_f="16786">2009</offsets></xref><offsets xml_i="27594" xml_f="28803" txt_i="16786" txt_f="17995">). Briefly muscle was snipped in ice-cold homogenizing buffer (50 mM Tris-HCL, 1 mM EDTA, 1 mM EGTA, 10 mM β-glycerophosphate, and 50 mM sodium fluoride). The homogenate was shaken for 10 min prior to being centrifuged at 1,000 g for 10 min at 4°C. The pellet was then re-suspended in homogenization buffer, before being shaken and centrifuged as described above. The myofibrillar fraction was separated from any collagen by dissolving the pellet in 0.3 M NaCl and heating for 30 min at 37°C. The proteins were then precipitated by combining the supernatant with 1 M PCA before being centrifuged for 20 min at 3500 rpm at 4°C. The pellet was then washed with 70% ethanol. The remaining myofibrillar pellet was hydrolyzed overnight at 110°C in 0.1 M HCl/Dowex 50W-X8 100–200 (Bio-Rad laboratories Inc., USA) and the liberated amino acids purified on cation-exchange columns (Bio-Rad laboratories Inc., USA). Amino acids were then converted to their N-acetyl-n-propyl ester derivative and phenylalanine labeling was determined by gas-chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS, Delta-plus XL, Thermofinnigan, Hemel Hempstead, UK). Ions 44/45 were monitored for unlabeled and labeled CO</offsets><sub><offsets xml_i="28808" xml_f="28809" txt_i="17995" txt_f="17996">2</offsets></sub><offsets xml_i="28815" xml_f="28830" txt_i="17996" txt_f="18011">, respectively.</offsets></p></sec><sec><title><offsets xml_i="28852" xml_f="28890" txt_i="18013" txt_f="18051">Intracellular phenylalanine enrichment</offsets></title><p><offsets xml_i="28901" xml_f="29465" txt_i="18052" txt_f="18616">Intracellular amino acids were liberated from ~20 mg of muscle. The frozen tissue was powdered under liquid nitrogen using a mortar and pestle and 500 μL of 1 M perchloric acid (PCA) was added. The mixture was centrifuged at 10,000 g for 10 min. The supernatant was then neutralized with 2 M potassium hydroxide and 0.2 M PCA and combined with 20 μL of urease for removal of urea. The free amino acids from the intracellular pool were purified on cation-exchange columns as described above. Intracellular amino acids were converted to their MTBSTFA derivative and </offsets><sup><offsets xml_i="29470" xml_f="29472" txt_i="18616" txt_f="18618">13</offsets></sup><offsets xml_i="29478" xml_f="29479" txt_i="18618" txt_f="18619">C</offsets><sub><offsets xml_i="29484" xml_f="29485" txt_i="18619" txt_f="18620">6</offsets></sub><offsets xml_i="29491" xml_f="29656" txt_i="18620" txt_f="18785"> phenylalanine enrichment was determined by monitoring at ions 234/240 using gas chromatography mass spectrometry (GCMS; model 5973; Hewlett Packard, Palo Alto, CA).</offsets></p></sec><sec><title><offsets xml_i="29678" xml_f="29694" txt_i="18787" txt_f="18803">Western blotting</offsets></title><p><offsets xml_i="29705" xml_f="29875" txt_i="18804" txt_f="18974">Muscle tissue (20–30 mg) was powdered on dry ice and then homogenized in lysis buffer (50 mM Tris pH 7.5; 250 mM Sucrose; 1 mM EDTA; 1 mM EGTA; 1% Triton X-100; 1 mM NaVO</offsets><sub><offsets xml_i="29880" xml_f="29881" txt_i="18974" txt_f="18975">4</offsets></sub><offsets xml_i="29887" xml_f="30705" txt_i="18975" txt_f="19793">; 50 mM NaF; 0.50% PIC) using a hand-held homogenizer (PRO200, UK). Samples were placed on a shaker for 1 h at 4°C, before being centrifuged for 5 min at 6,000 g. The supernatant was then used for determination of protein. A DC protein assay (Bio Rad, Hertfordshire, UK) was used for determining protein concentration. Equal amounts of protein were then boiled in Laemmli sample buffer (250 mM Tris-HCl, pH 6.8; 2% SDS; 10% glycerol; 0.01% bromophenol blue; 5% β-mercaptoethanol) and separated on SDS polyacrylamide gels (10–15%) for ~1 h at 58 mA. Proteins were then transferred to a Protran nitrocellulose membrane (Whatman, Dassel, Germany) at 100 V for 1 h. Membranes were blocked using milk solution and then incubated overnight at 4°C with the appropriate primary antibody. The primary antibodies used were: S6K1</offsets><sup><offsets xml_i="30710" xml_f="30716" txt_i="19793" txt_f="19799">Thr389</offsets></sup><offsets xml_i="30722" xml_f="30750" txt_i="19799" txt_f="19827"> (Cell signaling #9234); Akt</offsets><sup><offsets xml_i="30755" xml_f="30761" txt_i="19827" txt_f="19833">Ser473</offsets></sup><offsets xml_i="30767" xml_f="30798" txt_i="19833" txt_f="19864"> (Cell signaling #3787); 4E-BP1</offsets><sup><offsets xml_i="30803" xml_f="30811" txt_i="19864" txt_f="19872">Thr37/45</offsets></sup><offsets xml_i="30817" xml_f="30849" txt_i="19872" txt_f="19904"> (Santa Cruz SC6025); and PRAS40</offsets><sup><offsets xml_i="30854" xml_f="30860" txt_i="19904" txt_f="19910">Thr246</offsets></sup><offsets xml_i="30866" xml_f="31838" txt_i="19910" txt_f="20882"> (Cell Signaling #2610). The following morning the membrane was rinsed in wash buffer (TBS with 0.1% Tween-20) before being incubated for 1 h at room temperature with the appropriate secondary antibody; either horseradish (HRP)-linked anti-mouse IgG (New England Biolabs, 7072;1:1,000) or anti-rabbit IgG (New England Biolabs, 7074; 1:1,000) diluted in wash buffer. The membrane was then cleared of the antibody using wash buffer. Antibody binding was detected using enhanced chemiluminescence (Millipore, Billerica, MA). Imaging and band quantification were carried out using a Chemi Genius Bioimaging Gel Doc System (Syngene, Cambridge, UK). Blots were stripped in Restore™ Western Blot Stripping Buffer (Pierce, Rockford, IL) for 20 min and, re-blocked in milk solution and the respective total protein antibodies [S6K1 (Santa Cruz #sc-230); Akt (Cell signaling #9272); 4E-BP1 (Santa Cruz #sc-4251); and PRAS40 (Cell Signaling #2691)] were used to assure equal loading.</offsets></p></sec><sec><title><offsets xml_i="31860" xml_f="31889" txt_i="20884" txt_f="20913">Blood collection and analysis</offsets></title><p></p></sec><sec><title><offsets xml_i="31922" xml_f="31970" txt_i="20916" txt_f="20964">Plasma amino acid concentrations and enrichments</offsets></title><p><offsets xml_i="31981" xml_f="31985" txt_i="20965" txt_f="20969">The </offsets><sup><offsets xml_i="31990" xml_f="31992" txt_i="20969" txt_f="20971">13</offsets></sup><offsets xml_i="31998" xml_f="31999" txt_i="20971" txt_f="20972">C</offsets><sub><offsets xml_i="32004" xml_f="32005" txt_i="20972" txt_f="20973">6</offsets></sub><offsets xml_i="32011" xml_f="32465" txt_i="20973" txt_f="21427"> enrichments of phenylalanine and tyrosine were determined by GCMS by monitoring ions 234 and 240 for unlabeled and labeled phenylalanine and ions 466 and 472 for unlabeled and labeled tyrosine. Once thawed, plasma samples were mixed with diluted acetic acid and purified using a cation-exchange column (Bio-Rad laboratories Inc., USA). The amino acids were then converted to their N-tert-butyldimethyl-silyl-N-methyltrifluoracetamide (TBDMS) derivative.</offsets></p><p><offsets xml_i="32472" xml_f="32630" txt_i="21428" txt_f="21586">Simultaneously, concentrations of phenylalanine, leucine, threonine, isoleucine, and valine were determined using an internal standard method (Tipton et al., </offsets><xref rid="B41" ref-type="bibr"><offsets xml_i="32662" xml_f="32667" txt_i="21586" txt_f="21591">1999b</offsets></xref><offsets xml_i="32674" xml_f="32676" txt_i="21591" txt_f="21593">, </offsets><xref rid="B42" ref-type="bibr"><offsets xml_i="32708" xml_f="32712" txt_i="21593" txt_f="21597">2001</offsets></xref><offsets xml_i="32719" xml_f="32934" txt_i="21597" txt_f="21812">). The selected amino acids were chosen to monitor blood concentrations of essential, non-essential, and the BCAAs. Briefly, plasma samples were weighed to obtain ~300 μL, 30 μL of an internal standard containing U-</offsets><sup><offsets xml_i="32939" xml_f="32941" txt_i="21812" txt_f="21814">13</offsets></sup><offsets xml_i="32947" xml_f="32948" txt_i="21814" txt_f="21815">C</offsets><sub><offsets xml_i="32953" xml_f="32954" txt_i="21815" txt_f="21816">9</offsets></sub><offsets xml_i="32960" xml_f="32961" txt_i="21816" txt_f="21817">-</offsets><sup><offsets xml_i="32966" xml_f="32968" txt_i="21817" txt_f="21819">15</offsets></sup><offsets xml_i="32974" xml_f="33008" txt_i="21819" txt_f="21853">N phenylalanine (ions 336/346), U-</offsets><sup><offsets xml_i="33013" xml_f="33015" txt_i="21853" txt_f="21855">13</offsets></sup><offsets xml_i="33021" xml_f="33022" txt_i="21855" txt_f="21856">C</offsets><sub><offsets xml_i="33027" xml_f="33028" txt_i="21856" txt_f="21857">6</offsets></sub><offsets xml_i="33034" xml_f="33077" txt_i="21857" txt_f="21900"> leucine, and isoleucine (ions 302/308), U-</offsets><sup><offsets xml_i="33082" xml_f="33084" txt_i="21900" txt_f="21902">13</offsets></sup><offsets xml_i="33090" xml_f="33091" txt_i="21902" txt_f="21903">C</offsets><sub><offsets xml_i="33096" xml_f="33097" txt_i="21903" txt_f="21904">4</offsets></sub><offsets xml_i="33103" xml_f="33104" txt_i="21904" txt_f="21905">-</offsets><sup><offsets xml_i="33109" xml_f="33111" txt_i="21905" txt_f="21907">15</offsets></sup><offsets xml_i="33117" xml_f="33151" txt_i="21907" txt_f="21941">N threonine (ions 405/409), and U-</offsets><sup><offsets xml_i="33156" xml_f="33158" txt_i="21941" txt_f="21943">13</offsets></sup><offsets xml_i="33164" xml_f="33165" txt_i="21943" txt_f="21944">C</offsets><sub><offsets xml_i="33170" xml_f="33171" txt_i="21944" txt_f="21945">5</offsets></sub><offsets xml_i="33177" xml_f="33525" txt_i="21945" txt_f="22293"> valine (ions 288/293) was then added and weighed. Since the weight of both sample and internal standard was known, it was possible to calculate a tracer-to-tracee ratio. Since the amino acid concentrations of the internal standard were known, it was possible to convert the tracer-to-tracee ratio into a concentration of each amino acid in plasma.</offsets></p></sec><sec><title><offsets xml_i="33547" xml_f="33570" txt_i="22295" txt_f="22318">Plasma urea enrichments</offsets></title><p><offsets xml_i="33581" xml_f="33594" txt_i="22319" txt_f="22332">To determine </offsets><sup><offsets xml_i="33599" xml_f="33601" txt_i="22332" txt_f="22334">15</offsets></sup><offsets xml_i="33607" xml_f="33608" txt_i="22334" txt_f="22335">N</offsets><sub><offsets xml_i="33613" xml_f="33614" txt_i="22335" txt_f="22336">2</offsets></sub><offsets xml_i="33620" xml_f="34007" txt_i="22336" txt_f="22723"> urea enrichments, 10 μL of plasma was mixed with 120 μL ethanol. Samples were then left in the fridge for 30 min prior to centrifugation at 13,000 rpm for 20 min at 4°C. The supernatant was then removed and dried under nitrogen. TBDMS and acetonitrile were added to the dried sample prior to heating at 90°C for 90 min. Samples were then run on GCMS and ions 231 and 233 were monitored.</offsets></p></sec><sec><title><offsets xml_i="34029" xml_f="34041" txt_i="22725" txt_f="22737">Calculations</offsets></title><sec><title><offsets xml_i="34061" xml_f="34077" txt_i="22738" txt_f="22754">Myofibrillar MPS</offsets></title><p><offsets xml_i="34088" xml_f="34248" txt_i="22755" txt_f="22915">The fractional synthesis rate (FSR) of the myofibrillar protein fraction was calculated over the 4 h period using the standard precursor-product equation below:</offsets></p><disp-formula id="E1"><label><offsets xml_i="34281" xml_f="34284" txt_i="22916" txt_f="22919">(1)</offsets></label><mml:math id="M1"><mml:mtable class="eqnarray" columnalign="left"><mml:mtr><mml:mtd><mml:mi><offsets xml_i="34384" xml_f="34385" txt_i="22919" txt_f="22920">F</offsets></mml:mi><mml:mi><offsets xml_i="34402" xml_f="34403" txt_i="22920" txt_f="22921">S</offsets></mml:mi><mml:mi><offsets xml_i="34420" xml_f="34421" txt_i="22921" txt_f="22922">R</offsets></mml:mi><mml:mrow><mml:mo stretchy="true"><offsets xml_i="34464" xml_f="34465" txt_i="22922" txt_f="22923">(</offsets></mml:mo><mml:mrow><mml:mtext class="textrm" mathvariant="normal"><offsets xml_i="34531" xml_f="34532" txt_i="22923" txt_f="22924">%</offsets></mml:mtext><mml:mo><offsets xml_i="34552" xml_f="34553" txt_i="22924" txt_f="22925">·</offsets></mml:mo><mml:msup><mml:mrow><mml:mi><offsets xml_i="34590" xml_f="34591" txt_i="22925" txt_f="22926">h</offsets></mml:mi></mml:mrow><mml:mrow><mml:mo><offsets xml_i="34629" xml_f="34630" txt_i="22926" txt_f="22927">-</offsets></mml:mo><mml:mn><offsets xml_i="34647" xml_f="34648" txt_i="22927" txt_f="22928">1</offsets></mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo stretchy="true"><offsets xml_i="34714" xml_f="34715" txt_i="22928" txt_f="22929">)</offsets></mml:mo></mml:mrow><mml:mo><offsets xml_i="34743" xml_f="34744" txt_i="22929" txt_f="22930">=</offsets></mml:mo><mml:mrow><mml:mo stretchy="true"><offsets xml_i="34787" xml_f="34788" txt_i="22930" txt_f="22931">(</offsets></mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="34856" xml_f="34857" txt_i="22931" txt_f="22932">E</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="34895" xml_f="34896" txt_i="22932" txt_f="22933">B</offsets></mml:mi><mml:mn><offsets xml_i="34913" xml_f="34914" txt_i="22933" txt_f="22934">3</offsets></mml:mn></mml:mrow></mml:msub><mml:mo><offsets xml_i="34953" xml_f="34954" txt_i="22934" txt_f="22935">-</offsets></mml:mo><mml:msub><mml:mrow><mml:mi><offsets xml_i="34991" xml_f="34992" txt_i="22935" txt_f="22936">E</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="35030" xml_f="35031" txt_i="22936" txt_f="22937">B</offsets></mml:mi><mml:mn><offsets xml_i="35048" xml_f="35049" txt_i="22937" txt_f="22938">1</offsets></mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="35129" xml_f="35130" txt_i="22938" txt_f="22939">E</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="35168" xml_f="35169" txt_i="22939" txt_f="22940">I</offsets></mml:mi><mml:mi><offsets xml_i="35186" xml_f="35187" txt_i="22940" txt_f="22941">C</offsets></mml:mi></mml:mrow></mml:msub><mml:mo><offsets xml_i="35226" xml_f="35227" txt_i="22941" txt_f="22942">·</offsets></mml:mo><mml:mi><offsets xml_i="35244" xml_f="35245" txt_i="22942" txt_f="22943">t</offsets></mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true"><offsets xml_i="35312" xml_f="35313" txt_i="22943" txt_f="22944">)</offsets></mml:mo></mml:mrow><mml:mo><offsets xml_i="35341" xml_f="35342" txt_i="22944" txt_f="22945">·</offsets></mml:mo><mml:mn><offsets xml_i="35359" xml_f="35362" txt_i="22945" txt_f="22948">100</offsets></mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula><p><offsets xml_i="35433" xml_f="35439" txt_i="22948" txt_f="22954">Where </offsets><italic><offsets xml_i="35447" xml_f="35448" txt_i="22954" txt_f="22955">E</offsets></italic><sub><italic><offsets xml_i="35470" xml_f="35471" txt_i="22955" txt_f="22956">B</offsets></italic></sub><offsets xml_i="35486" xml_f="35488" txt_i="22956" txt_f="22958"> (</offsets><sub><italic><offsets xml_i="35501" xml_f="35502" txt_i="22958" txt_f="22959">B</offsets></italic><offsets xml_i="35511" xml_f="35512" txt_i="22959" txt_f="22960">3</offsets></sub><offsets xml_i="35518" xml_f="35532" txt_i="22960" txt_f="22974"> is the bound </offsets><sup><offsets xml_i="35537" xml_f="35539" txt_i="22974" txt_f="22976">13</offsets></sup><offsets xml_i="35545" xml_f="35546" txt_i="22976" txt_f="22977">C</offsets><sub><offsets xml_i="35551" xml_f="35552" txt_i="22977" txt_f="22978">6</offsets></sub><offsets xml_i="35558" xml_f="35639" txt_i="22978" txt_f="23059"> phenylalanine enrichment measured in the biopsy collected at the 4h time point, </offsets><italic><offsets xml_i="35647" xml_f="35648" txt_i="23059" txt_f="23060">B</offsets></italic><sub><offsets xml_i="35662" xml_f="35663" txt_i="23060" txt_f="23061">1</offsets></sub><offsets xml_i="35669" xml_f="35683" txt_i="23061" txt_f="23075"> is the bound </offsets><sup><offsets xml_i="35688" xml_f="35690" txt_i="23075" txt_f="23077">13</offsets></sup><offsets xml_i="35696" xml_f="35697" txt_i="23077" txt_f="23078">C</offsets><sub><offsets xml_i="35702" xml_f="35703" txt_i="23078" txt_f="23079">6</offsets></sub><offsets xml_i="35709" xml_f="35792" txt_i="23079" txt_f="23162"> phenylalanine enrichment measured in the biopsy collected at the 0 h time point), </offsets><italic><offsets xml_i="35800" xml_f="35801" txt_i="23162" txt_f="23163">E</offsets></italic><sub><italic><offsets xml_i="35823" xml_f="35825" txt_i="23163" txt_f="23165">IC</offsets></italic></sub><offsets xml_i="35840" xml_f="35856" txt_i="23165" txt_f="23181"> is the average </offsets><italic><offsets xml_i="35864" xml_f="35866" txt_i="23181" txt_f="23183">IC</offsets></italic><offsets xml_i="35875" xml_f="35941" txt_i="23183" txt_f="23249"> phenylalanine enrichment of biopsies collected at 0 and 4 h, and </offsets><italic><offsets xml_i="35949" xml_f="35950" txt_i="23249" txt_f="23250">t</offsets></italic><offsets xml_i="35959" xml_f="35996" txt_i="23250" txt_f="23287"> is time of tracer incorporation (h).</offsets></p></sec><sec><title><offsets xml_i="36018" xml_f="36050" txt_i="23289" txt_f="23321">Endogenous urea production rates</offsets></title><p><offsets xml_i="36061" xml_f="36106" txt_i="23322" txt_f="23367">The rate of urea production over time (μmol·h</offsets><sup><offsets xml_i="36111" xml_f="36113" txt_i="23367" txt_f="23369">−1</offsets></sup><offsets xml_i="36119" xml_f="36124" txt_i="23369" txt_f="23374">·kgBM</offsets><sup><offsets xml_i="36129" xml_f="36131" txt_i="23374" txt_f="23376">−1</offsets></sup><offsets xml_i="36137" xml_f="36209" txt_i="23376" txt_f="23448">) was calculated as previously described (Equation 2; Jahoor and Wolfe, </offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="36241" xml_f="36245" txt_i="23448" txt_f="23452">1987</offsets></xref><offsets xml_i="36252" xml_f="36254" txt_i="23452" txt_f="23454">).</offsets></p><disp-formula id="E2"><label><offsets xml_i="36287" xml_f="36290" txt_i="23455" txt_f="23458">(2)</offsets></label><mml:math id="M2"><mml:mtable class="eqnarray" columnalign="left"><mml:mtr><mml:mtd><mml:mi><offsets xml_i="36390" xml_f="36391" txt_i="23458" txt_f="23459">P</offsets></mml:mi><mml:mi><offsets xml_i="36408" xml_f="36409" txt_i="23459" txt_f="23460">r</offsets></mml:mi><mml:mi><offsets xml_i="36426" xml_f="36427" txt_i="23460" txt_f="23461">o</offsets></mml:mi><mml:mi><offsets xml_i="36444" xml_f="36445" txt_i="23461" txt_f="23462">d</offsets></mml:mi><mml:mi><offsets xml_i="36462" xml_f="36463" txt_i="23462" txt_f="23463">u</offsets></mml:mi><mml:mi><offsets xml_i="36480" xml_f="36481" txt_i="23463" txt_f="23464">c</offsets></mml:mi><mml:mi><offsets xml_i="36498" xml_f="36499" txt_i="23464" txt_f="23465">t</offsets></mml:mi><mml:mi><offsets xml_i="36516" xml_f="36517" txt_i="23465" txt_f="23466">i</offsets></mml:mi><mml:mi><offsets xml_i="36534" xml_f="36535" txt_i="23466" txt_f="23467">o</offsets></mml:mi><mml:mi><offsets xml_i="36552" xml_f="36553" txt_i="23467" txt_f="23468">n</offsets></mml:mi><mml:mtext><offsets xml_i="36573" xml_f="36574" txt_i="23468" txt_f="23469"> </offsets></mml:mtext><mml:mo><offsets xml_i="36594" xml_f="36595" txt_i="23469" txt_f="23470">=</offsets></mml:mo><mml:mtext><offsets xml_i="36615" xml_f="36616" txt_i="23470" txt_f="23471"> </offsets></mml:mtext><mml:mrow><mml:mo stretchy="true"><offsets xml_i="36662" xml_f="36663" txt_i="23471" txt_f="23472">(</offsets></mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="true"><offsets xml_i="36716" xml_f="36717" txt_i="23472" txt_f="23473">(</offsets></mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="36785" xml_f="36786" txt_i="23473" txt_f="23474">E</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="36824" xml_f="36825" txt_i="23474" txt_f="23475">u</offsets></mml:mi><mml:mi><offsets xml_i="36842" xml_f="36843" txt_i="23475" txt_f="23476">i</offsets></mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="36923" xml_f="36924" txt_i="23476" txt_f="23477">E</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="36962" xml_f="36963" txt_i="23477" txt_f="23478">u</offsets></mml:mi><mml:mi><offsets xml_i="36980" xml_f="36981" txt_i="23478" txt_f="23479">p</offsets></mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true"><offsets xml_i="37070" xml_f="37071" txt_i="23479" txt_f="23480">)</offsets></mml:mo></mml:mrow><mml:mo><offsets xml_i="37099" xml_f="37100" txt_i="23480" txt_f="23481">-</offsets></mml:mo><mml:mn><offsets xml_i="37117" xml_f="37118" txt_i="23481" txt_f="23482">1</offsets></mml:mn></mml:mrow><mml:mo stretchy="true"><offsets xml_i="37162" xml_f="37163" txt_i="23482" txt_f="23483">)</offsets></mml:mo></mml:mrow><mml:mo><offsets xml_i="37191" xml_f="37192" txt_i="23483" txt_f="23484">·</offsets></mml:mo><mml:mi><offsets xml_i="37209" xml_f="37210" txt_i="23484" txt_f="23485">i</offsets></mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula><p><offsets xml_i="37281" xml_f="37287" txt_i="23485" txt_f="23491">where </offsets><italic><offsets xml_i="37295" xml_f="37296" txt_i="23491" txt_f="23492">i</offsets></italic><offsets xml_i="37305" xml_f="37353" txt_i="23492" txt_f="23540"> is the infusion rate of the urea tracer (μmol·h</offsets><sup><offsets xml_i="37358" xml_f="37360" txt_i="23540" txt_f="23542">−1</offsets></sup><offsets xml_i="37366" xml_f="37371" txt_i="23542" txt_f="23547">·kgBM</offsets><sup><offsets xml_i="37376" xml_f="37378" txt_i="23547" txt_f="23549">−1</offsets></sup><offsets xml_i="37384" xml_f="37390" txt_i="23549" txt_f="23555">) and </offsets><italic><offsets xml_i="37398" xml_f="37399" txt_i="23555" txt_f="23556">E</offsets></italic><sub><italic><offsets xml_i="37421" xml_f="37423" txt_i="23556" txt_f="23558">up</offsets></italic></sub><offsets xml_i="37438" xml_f="37443" txt_i="23558" txt_f="23563"> and </offsets><italic><offsets xml_i="37451" xml_f="37452" txt_i="23563" txt_f="23564">E</offsets></italic><sub><italic><offsets xml_i="37474" xml_f="37476" txt_i="23564" txt_f="23566">ui</offsets></italic></sub><offsets xml_i="37491" xml_f="37561" txt_i="23566" txt_f="23636"> are the enrichments of urea in the plasma and infusate, respectively.</offsets></p></sec><sec><title><offsets xml_i="37583" xml_f="37605" txt_i="23638" txt_f="23660">Phenylalanine kinetics</offsets></title><p><offsets xml_i="37616" xml_f="37781" txt_i="23661" txt_f="23826">Whole body phenylalanine rate of appearance was calculated by dividing the infusion rate by plasma phenylalanine enrichment, as described previously (Tipton et al., </offsets><xref rid="B40" ref-type="bibr"><offsets xml_i="37813" xml_f="37817" txt_i="23826" txt_f="23830">1996</offsets></xref><offsets xml_i="37824" xml_f="37925" txt_i="23830" txt_f="23931">). Phenylalanine oxidation was calculated by using the phenylalanine balance model (Thompson et al., </offsets><xref rid="B37" ref-type="bibr"><offsets xml_i="37957" xml_f="37961" txt_i="23931" txt_f="23935">1989</offsets></xref><offsets xml_i="37968" xml_f="38083" txt_i="23935" txt_f="24050">). Briefly, whole body phenylalanine oxidation was determined from the calculation of the hydroxylation of L-[ring-</offsets><sup><offsets xml_i="38088" xml_f="38090" txt_i="24050" txt_f="24052">13</offsets></sup><offsets xml_i="38096" xml_f="38097" txt_i="24052" txt_f="24053">C</offsets><sub><offsets xml_i="38102" xml_f="38103" txt_i="24053" txt_f="24054">6</offsets></sub><offsets xml_i="38109" xml_f="38135" txt_i="24054" txt_f="24080">]phenylalanine to L-[ring-</offsets><sup><offsets xml_i="38140" xml_f="38142" txt_i="24080" txt_f="24082">13</offsets></sup><offsets xml_i="38148" xml_f="38149" txt_i="24082" txt_f="24083">C</offsets><sub><offsets xml_i="38154" xml_f="38155" txt_i="24083" txt_f="24084">6</offsets></sub><offsets xml_i="38161" xml_f="38201" txt_i="24084" txt_f="24124">]tyrosine (Equation 3; Thompson et al., </offsets><xref rid="B37" ref-type="bibr"><offsets xml_i="38233" xml_f="38237" txt_i="24124" txt_f="24128">1989</offsets></xref><offsets xml_i="38244" xml_f="38246" txt_i="24128" txt_f="24130">).</offsets></p><disp-formula id="E3"><label><offsets xml_i="38279" xml_f="38282" txt_i="24131" txt_f="24134">(3)</offsets></label><mml:math id="M3"><mml:mtable class="eqnarray" columnalign="left"><mml:mtr><mml:mtd><mml:mi><offsets xml_i="38382" xml_f="38383" txt_i="24134" txt_f="24135">Q</offsets></mml:mi><mml:mi><offsets xml_i="38400" xml_f="38401" txt_i="24135" txt_f="24136">p</offsets></mml:mi><mml:mi><offsets xml_i="38418" xml_f="38419" txt_i="24136" txt_f="24137">t</offsets></mml:mi><mml:mtext><offsets xml_i="38439" xml_f="38440" txt_i="24137" txt_f="24138"> </offsets></mml:mtext><mml:mo><offsets xml_i="38460" xml_f="38461" txt_i="24138" txt_f="24139">=</offsets></mml:mo><mml:mtext><offsets xml_i="38481" xml_f="38482" txt_i="24139" txt_f="24140"> </offsets></mml:mtext><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="38543" xml_f="38544" txt_i="24140" txt_f="24141">P</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="38582" xml_f="38583" txt_i="24141" txt_f="24142">t</offsets></mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="38663" xml_f="38664" txt_i="24142" txt_f="24143">P</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="38702" xml_f="38703" txt_i="24143" txt_f="24144">p</offsets></mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo><offsets xml_i="38765" xml_f="38766" txt_i="24144" txt_f="24145">·</offsets></mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi><offsets xml_i="38827" xml_f="38828" txt_i="24145" txt_f="24146">Q</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="38866" xml_f="38867" txt_i="24146" txt_f="24147">p</offsets></mml:mi></mml:mrow><mml:mrow><mml:mn><offsets xml_i="38905" xml_f="38906" txt_i="24147" txt_f="24148">2</offsets></mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mrow><mml:mo stretchy="true"><offsets xml_i="38995" xml_f="38996" txt_i="24148" txt_f="24149">(</offsets></mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="39064" xml_f="39065" txt_i="24149" txt_f="24150">E</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="39103" xml_f="39104" txt_i="24150" txt_f="24151">p</offsets></mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="39184" xml_f="39185" txt_i="24151" txt_f="24152">E</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="39223" xml_f="39224" txt_i="24152" txt_f="24153">t</offsets></mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo><offsets xml_i="39286" xml_f="39287" txt_i="24153" txt_f="24154">-</offsets></mml:mo><mml:mn><offsets xml_i="39304" xml_f="39305" txt_i="24154" txt_f="24155">1</offsets></mml:mn></mml:mrow><mml:mo stretchy="true"><offsets xml_i="39349" xml_f="39350" txt_i="24155" txt_f="24156">)</offsets></mml:mo></mml:mrow><mml:mo><offsets xml_i="39378" xml_f="39379" txt_i="24156" txt_f="24157">·</offsets></mml:mo><mml:mrow><mml:mo stretchy="true"><offsets xml_i="39422" xml_f="39423" txt_i="24157" txt_f="24158">(</offsets></mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi><offsets xml_i="39470" xml_f="39471" txt_i="24158" txt_f="24159">i</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="39509" xml_f="39510" txt_i="24159" txt_f="24160">p</offsets></mml:mi></mml:mrow></mml:msub><mml:mo><offsets xml_i="39549" xml_f="39550" txt_i="24160" txt_f="24161">+</offsets></mml:mo><mml:msub><mml:mrow><mml:mi><offsets xml_i="39587" xml_f="39588" txt_i="24161" txt_f="24162">Q</offsets></mml:mi></mml:mrow><mml:mrow><mml:mi><offsets xml_i="39626" xml_f="39627" txt_i="24162" txt_f="24163">p</offsets></mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="true"><offsets xml_i="39693" xml_f="39694" txt_i="24163" txt_f="24164">)</offsets></mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula><p><offsets xml_i="39799" xml_f="39806" txt_i="24164" txt_f="24171">Where, </offsets><italic><offsets xml_i="39814" xml_f="39815" txt_i="24171" txt_f="24172">P</offsets></italic><sub><italic><offsets xml_i="39837" xml_f="39838" txt_i="24172" txt_f="24173">t</offsets></italic></sub><offsets xml_i="39853" xml_f="39854" txt_i="24173" txt_f="24174">/</offsets><italic><offsets xml_i="39862" xml_f="39863" txt_i="24174" txt_f="24175">P</offsets></italic><sub><italic><offsets xml_i="39885" xml_f="39886" txt_i="24175" txt_f="24176">p</offsets></italic></sub><offsets xml_i="39901" xml_f="39944" txt_i="24176" txt_f="24219"> is estimated to be 0.73 (Thompson et al., </offsets><xref rid="B37" ref-type="bibr"><offsets xml_i="39976" xml_f="39980" txt_i="24219" txt_f="24223">1989</offsets></xref><offsets xml_i="39987" xml_f="39990" txt_i="24223" txt_f="24226">). </offsets><italic><offsets xml_i="39998" xml_f="39999" txt_i="24226" txt_f="24227">Q</offsets></italic><sub><italic><offsets xml_i="40021" xml_f="40022" txt_i="24227" txt_f="24228">p</offsets></italic></sub><offsets xml_i="40037" xml_f="40071" txt_i="24228" txt_f="24262"> is the phenylalanine flux (μmol·h</offsets><sup><offsets xml_i="40076" xml_f="40078" txt_i="24262" txt_f="24264">−1</offsets></sup><offsets xml_i="40084" xml_f="40089" txt_i="24264" txt_f="24269">·kgBM</offsets><sup><offsets xml_i="40094" xml_f="40096" txt_i="24269" txt_f="24271">−1</offsets></sup><offsets xml_i="40102" xml_f="40105" txt_i="24271" txt_f="24274">), </offsets><italic><offsets xml_i="40113" xml_f="40114" txt_i="24274" txt_f="24275">i</offsets></italic><offsets xml_i="40123" xml_f="40166" txt_i="24275" txt_f="24318"> is the infusion rate of the tracer (μmol·h</offsets><sup><offsets xml_i="40171" xml_f="40173" txt_i="24318" txt_f="24320">−1</offsets></sup><offsets xml_i="40179" xml_f="40184" txt_i="24320" txt_f="24325">·kgBM</offsets><sup><offsets xml_i="40189" xml_f="40191" txt_i="24325" txt_f="24327">−1</offsets></sup><offsets xml_i="40197" xml_f="40203" txt_i="24327" txt_f="24333">) and </offsets><italic><offsets xml_i="40211" xml_f="40212" txt_i="24333" txt_f="24334">E</offsets></italic><sub><italic><offsets xml_i="40234" xml_f="40235" txt_i="24334" txt_f="24335">p</offsets></italic></sub><offsets xml_i="40250" xml_f="40255" txt_i="24335" txt_f="24340"> and </offsets><italic><offsets xml_i="40263" xml_f="40264" txt_i="24340" txt_f="24341">E</offsets></italic><sub><italic><offsets xml_i="40286" xml_f="40287" txt_i="24341" txt_f="24342">t</offsets></italic></sub><offsets xml_i="40302" xml_f="40364" txt_i="24342" txt_f="24404"> are the respective enrichments of phenylalanine and tyrosine.</offsets></p></sec></sec><sec><title><offsets xml_i="40392" xml_f="40434" txt_i="24407" txt_f="24449">Statistical analyses and data presentation</offsets></title><p><offsets xml_i="40445" xml_f="40794" txt_i="24450" txt_f="24799">Total area under the curve (tAUC) for serum insulin concentrations, phenylalanine Ra, and phenylalanine oxidation rates were calculated using Graphpad Prism V5.0 (Graphpad software incorporation, La Jolle, California, USA). tAUC-values were calculated from drink ingestion to final blood sample and a baseline y-axis value of zero for each was used.</offsets></p><p><offsets xml_i="40801" xml_f="41290" txt_i="24800" txt_f="25289">A two-way repeated measures ANOVA was used to analyse blood glucose, insulin, amino acid, and urea concentrations, whole body urea production rates, phenylalanine Ra, phenylalanine oxidation rates, and phenylalanine/tyrosine enrichments (within-subject factor: time point; between-subject factor: trial). Exercise variables, myofibrillar-MPS, and tAUC of serum insulin concentrations, and phenylalanine kinetics for the post-exercise period were analyzed using a paired samples one-tailed </offsets><italic><offsets xml_i="41298" xml_f="41299" txt_i="25289" txt_f="25290">t</offsets></italic><offsets xml_i="41308" xml_f="41374" txt_i="25290" txt_f="25356">-test. Western blot data were expressed as percentage change from </offsets><italic><offsets xml_i="41382" xml_f="41383" txt_i="25356" txt_f="25357">t</offsets></italic><offsets xml_i="41392" xml_f="41604" txt_i="25357" txt_f="25569"> = 0 (immediately post-exercise muscle biopsy) and data were analyzed using a two-way repeated measures ANOVA. Given the large variability associated with phosphorylation measurements of anabolic cell signaling, </offsets><italic><offsets xml_i="41612" xml_f="41620" txt_i="25569" txt_f="25577">a priori</offsets></italic><offsets xml_i="41629" xml_f="41742" txt_i="25577" txt_f="25690"> we decided to explore differences over time for each trial separately. Significance for all analyses was set at </offsets><italic><offsets xml_i="41750" xml_f="41751" txt_i="25690" txt_f="25691">P</offsets></italic><offsets xml_i="41760" xml_f="41834" txt_i="25691" txt_f="25762"> &lt; 0.05. Where significance was detected, a LSD correction was used in </offsets><italic><offsets xml_i="41842" xml_f="41850" txt_i="25762" txt_f="25770">post-hoc</offsets></italic><offsets xml_i="41859" xml_f="42062" txt_i="25770" txt_f="25973"> analysis. All statistical tests were completed using statistical package for social sciences version 23.0 (IBM, Chicago, Illinois, USA). All values are presented as means ± SEM, unless otherwise stated.</offsets></p></sec></sec><sec sec-type="results" id="s3"><title><offsets xml_i="42117" xml_f="42124" txt_i="25976" txt_f="25983">Results</offsets></title><sec><title><offsets xml_i="42144" xml_f="42162" txt_i="25984" txt_f="26002">Exercise variables</offsets></title><p><offsets xml_i="42173" xml_f="42290" txt_i="26003" txt_f="26120">The lean tissue mass of the exercised leg, measured prior to each experimental protocol, was similar between trials (</offsets><italic><offsets xml_i="42298" xml_f="42299" txt_i="26120" txt_f="26121">P</offsets></italic><offsets xml_i="42308" xml_f="42475" txt_i="26121" txt_f="26285"> &gt; 0.05). The total weight lifted throughout the exercise protocol (including warm-up) was similar between BCAA (11,055 ± 837 kg) and PLA (11,089 ± 913 kg) trials (</offsets><italic><offsets xml_i="42483" xml_f="42484" txt_i="26285" txt_f="26286">P</offsets></italic><offsets xml_i="42493" xml_f="42565" txt_i="26286" txt_f="26358"> = 0.88) and participants reported RPE scores 19 in all exercise trials.</offsets></p></sec><sec><title><offsets xml_i="42587" xml_f="42640" txt_i="26360" txt_f="26413">Blood glucose, insulin, and amino acid concentrations</offsets></title><p><offsets xml_i="42651" xml_f="42707" txt_i="26414" txt_f="26470">Plasma glucose concentrations did not change over time (</offsets><italic><offsets xml_i="42715" xml_f="42716" txt_i="26470" txt_f="26471">P</offsets></italic><offsets xml_i="42725" xml_f="42765" txt_i="26471" txt_f="26511"> = 0.093), were similar between trials (</offsets><italic><offsets xml_i="42773" xml_f="42774" txt_i="26511" txt_f="26512">P</offsets></italic><offsets xml_i="42783" xml_f="42849" txt_i="26512" txt_f="26578"> = 0.365; data not shown) and no interaction effect was observed (</offsets><italic><offsets xml_i="42857" xml_f="42858" txt_i="26578" txt_f="26579">P</offsets></italic><offsets xml_i="42867" xml_f="42950" txt_i="26579" txt_f="26662"> = 0.548). In both trials, serum insulin concentrations markedly (264%) increased (</offsets><italic><offsets xml_i="42958" xml_f="42959" txt_i="26662" txt_f="26663">P</offsets></italic><offsets xml_i="42968" xml_f="43215" txt_i="26663" txt_f="26907"> &lt; 0.01) in response to breakfast, before returning to baseline 1 h after exercise and remained stable over the remainder of the recovery period (data not shown). There were no differences in insulin concentrations between BCAA and PLA trials (</offsets><italic><offsets xml_i="43223" xml_f="43224" txt_i="26907" txt_f="26908">P</offsets></italic><offsets xml_i="43233" xml_f="43282" txt_i="26908" txt_f="26957"> = 0.48) and no interaction effect was observed (</offsets><italic><offsets xml_i="43290" xml_f="43291" txt_i="26957" txt_f="26958">P</offsets></italic><offsets xml_i="43300" xml_f="43375" txt_i="26958" txt_f="27033"> = 0.36). The insulin tAUC over 4 h following drink ingestion was similar (</offsets><italic><offsets xml_i="43383" xml_f="43384" txt_i="27033" txt_f="27034">P</offsets></italic><offsets xml_i="43393" xml_f="43430" txt_i="27034" txt_f="27071"> = 0.70) between BCAA (50 ± 17 μIU·mL</offsets><sup><offsets xml_i="43435" xml_f="43437" txt_i="27071" txt_f="27073">−1</offsets></sup><offsets xml_i="43443" xml_f="43444" txt_i="27073" txt_f="27074">
</offsets><sup><offsets xml_i="43449" xml_f="43450" txt_i="27074" txt_f="27075">*</offsets></sup><offsets xml_i="43456" xml_f="43488" txt_i="27075" txt_f="27107">240 min) and PLA (53 ± 19 μIU·mL</offsets><sup><offsets xml_i="43493" xml_f="43495" txt_i="27107" txt_f="27109">−1</offsets></sup><offsets xml_i="43501" xml_f="43502" txt_i="27109" txt_f="27110">
</offsets><sup><offsets xml_i="43507" xml_f="43508" txt_i="27110" txt_f="27111">*</offsets></sup><offsets xml_i="43514" xml_f="43530" txt_i="27111" txt_f="27127">240 min) trials.</offsets></p><p><offsets xml_i="43537" xml_f="43614" txt_i="27128" txt_f="27205">A significant time effect was observed for plasma concentrations of leucine (</offsets><italic><offsets xml_i="43622" xml_f="43623" txt_i="27205" txt_f="27206">P</offsets></italic><offsets xml_i="43632" xml_f="43658" txt_i="27206" txt_f="27229"> &lt; 0.001), isoleucine (</offsets><italic><offsets xml_i="43666" xml_f="43667" txt_i="27229" txt_f="27230">P</offsets></italic><offsets xml_i="43676" xml_f="43702" txt_i="27230" txt_f="27253"> &lt; 0.001), and valine (</offsets><italic><offsets xml_i="43710" xml_f="43711" txt_i="27253" txt_f="27254">P</offsets></italic><offsets xml_i="43720" xml_f="43740" txt_i="27254" txt_f="27271"> &lt; 0.001; Figure </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="43770" xml_f="43771" txt_i="27271" txt_f="27272">2</offsets></xref><offsets xml_i="43778" xml_f="43865" txt_i="27272" txt_f="27359">). The concentrations of all branched chain amino acids were greater in BCAA than PLA (</offsets><italic><offsets xml_i="43873" xml_f="43874" txt_i="27359" txt_f="27360">P</offsets></italic><offsets xml_i="43883" xml_f="44322" txt_i="27360" txt_f="27796"> &lt; 0.001). Peak leucine (624 ± 41 μM), isoleucine (339 ± 23 μM), and valine (753 ± 45 μM) concentrations were observed at 0.5 h-post drink ingestion in BCAA.percentage increase from baseline of 300 ± 96% (leucine), 300 ± 88% (isoleucine), and 144 ± 59% (valine). A significant interaction effect for plasma branched chain amino acid concentrations was observed whereby over the entire measurement period after drink ingestion, leucine (</offsets><italic><offsets xml_i="44330" xml_f="44331" txt_i="27796" txt_f="27797">P</offsets></italic><offsets xml_i="44340" xml_f="44366" txt_i="27797" txt_f="27820"> &lt; 0.001), and valine (</offsets><italic><offsets xml_i="44374" xml_f="44375" txt_i="27820" txt_f="27821">P</offsets></italic><offsets xml_i="44384" xml_f="44521" txt_i="27821" txt_f="27958"> ≤ 0.002) concentrations were greater in BCAA than PLA. Over a 3.5 h period post drink ingestion, isoleucine levels were higher in BCAA (</offsets><italic><offsets xml_i="44529" xml_f="44530" txt_i="27958" txt_f="27959">P</offsets></italic><offsets xml_i="44539" xml_f="44549" txt_i="27959" txt_f="27969"> ≤ 0.001).</offsets></p><fig id="F2" position="float"><label><offsets xml_i="44590" xml_f="44598" txt_i="27970" txt_f="27978">Figure 2</offsets></label><caption><p><offsets xml_i="44618" xml_f="44643" txt_i="27978" txt_f="28003">Plasma concentrations of </offsets><bold><offsets xml_i="44649" xml_f="44652" txt_i="28003" txt_f="28006">(A)</offsets></bold><offsets xml_i="44659" xml_f="44669" txt_i="28006" txt_f="28016"> leucine, </offsets><bold><offsets xml_i="44675" xml_f="44678" txt_i="28016" txt_f="28019">(B)</offsets></bold><offsets xml_i="44685" xml_f="44698" txt_i="28019" txt_f="28032"> isoleucine, </offsets><bold><offsets xml_i="44704" xml_f="44707" txt_i="28032" txt_f="28035">(C)</offsets></bold><offsets xml_i="44714" xml_f="44723" txt_i="28035" txt_f="28044"> valine, </offsets><bold><offsets xml_i="44729" xml_f="44732" txt_i="28044" txt_f="28047">(D)</offsets></bold><offsets xml_i="44739" xml_f="44759" txt_i="28047" txt_f="28067"> phenylalanine, and </offsets><bold><offsets xml_i="44765" xml_f="44768" txt_i="28067" txt_f="28070">(E)</offsets></bold><offsets xml_i="44775" xml_f="44989" txt_i="28070" txt_f="28284"> threonine pre and post ingestion of either a branched-chain amino acid containing drink (BCAA, closed circles) or placebo drink (PLA, open circles) following resistance exercise. Data are displayed as means ± SE. </offsets><sup><offsets xml_i="44994" xml_f="44995" txt_i="28284" txt_f="28285">*</offsets></sup><offsets xml_i="45001" xml_f="45040" txt_i="28285" txt_f="28324">Significant difference between trials (</offsets><italic><offsets xml_i="45048" xml_f="45049" txt_i="28324" txt_f="28325">P</offsets></italic><offsets xml_i="45058" xml_f="45070" txt_i="28325" txt_f="28334"> &lt; 0.05).</offsets></p></caption><graphic xlink:href="fphys-08-00390-g0002"></graphic></fig><p><offsets xml_i="45146" xml_f="45261" txt_i="28335" txt_f="28450">Phenylalanine and threonine concentrations declined to below baseline values after drink ingestion in both trials (</offsets><italic><offsets xml_i="45269" xml_f="45270" txt_i="28450" txt_f="28451">P</offsets></italic><offsets xml_i="45279" xml_f="45362" txt_i="28451" txt_f="28531"> &lt; 0.001). There were no difference in threonine concentrations between trials (</offsets><italic><offsets xml_i="45370" xml_f="45371" txt_i="28531" txt_f="28532">P</offsets></italic><offsets xml_i="45380" xml_f="45430" txt_i="28532" txt_f="28582"> = 0.207) and no interaction effect was observed (</offsets><italic><offsets xml_i="45438" xml_f="45439" txt_i="28582" txt_f="28583">P</offsets></italic><offsets xml_i="45448" xml_f="45511" txt_i="28583" txt_f="28646"> = 0.056). Phenylalanine concentrations (main effect of trial; </offsets><italic><offsets xml_i="45519" xml_f="45520" txt_i="28646" txt_f="28647">P</offsets></italic><offsets xml_i="45529" xml_f="45615" txt_i="28647" txt_f="28733"> = 0.003) were significantly higher in BCAA than PLA at 15 min (83 ± 5 vs. 75 ± 8 μM, </offsets><italic><offsets xml_i="45623" xml_f="45624" txt_i="28733" txt_f="28734">P</offsets></italic><offsets xml_i="45633" xml_f="45719" txt_i="28734" txt_f="28820"> = 0.018), but significantly lower in BCAA than PLA at 120 min (57 ± 9 vs. 67 ± 8 μM, </offsets><italic><offsets xml_i="45727" xml_f="45728" txt_i="28820" txt_f="28821">P</offsets></italic><offsets xml_i="45737" xml_f="45779" txt_i="28821" txt_f="28863"> = 0.003), 150 min (58 ± 7 vs. 65 ± 9 μM, </offsets><italic><offsets xml_i="45787" xml_f="45788" txt_i="28863" txt_f="28864">P</offsets></italic><offsets xml_i="45797" xml_f="45844" txt_i="28864" txt_f="28911"> = 0.007), and 240 min (63 ± 6 vs. 73 ± 13 μM, </offsets><italic><offsets xml_i="45852" xml_f="45853" txt_i="28911" txt_f="28912">P</offsets></italic><offsets xml_i="45862" xml_f="45893" txt_i="28912" txt_f="28943"> = 0.021) post drink ingestion.</offsets></p></sec><sec><title><offsets xml_i="45915" xml_f="45977" txt_i="28945" txt_f="29007">Blood urea concentrations and whole-body urea production rates</offsets></title><p><offsets xml_i="45988" xml_f="46111" txt_i="29008" txt_f="29131">A decrease in plasma urea concentrations was observed in both trials during the latter stage (3–4 h) of exercise recovery (</offsets><italic><offsets xml_i="46119" xml_f="46120" txt_i="29131" txt_f="29132">P</offsets></italic><offsets xml_i="46129" xml_f="46179" txt_i="29132" txt_f="29179"> &lt; 0.026), with no differences between trials (</offsets><italic><offsets xml_i="46187" xml_f="46188" txt_i="29179" txt_f="29180">P</offsets></italic><offsets xml_i="46197" xml_f="46337" txt_i="29180" txt_f="29320"> = 0.733; data not shown). Whole body urea production rates decreased from immediately post-exercise to the end of the 4 h recovery period (</offsets><italic><offsets xml_i="46345" xml_f="46346" txt_i="29320" txt_f="29321">P</offsets></italic><offsets xml_i="46355" xml_f="46434" txt_i="29321" txt_f="29397"> &lt; 0.001; data not shown), however there was no differences between trials (</offsets><italic><offsets xml_i="46442" xml_f="46443" txt_i="29397" txt_f="29398">P</offsets></italic><offsets xml_i="46452" xml_f="46502" txt_i="29398" txt_f="29448"> = 0.685) and no interaction effect was observed (</offsets><italic><offsets xml_i="46510" xml_f="46511" txt_i="29448" txt_f="29449">P</offsets></italic><offsets xml_i="46520" xml_f="46651" txt_i="29449" txt_f="29580"> = 0.611). The tAUC of urea production in response to post-exercise drink ingestion was similar between BCAA (2,314 ± 490 μmol·kgBM</offsets><sup><offsets xml_i="46656" xml_f="46658" txt_i="29580" txt_f="29582">−1</offsets></sup><offsets xml_i="46664" xml_f="46696" txt_i="29582" txt_f="29614">) and PLA (2,272 ± 636 μmol·kgBM</offsets><sup><offsets xml_i="46701" xml_f="46703" txt_i="29614" txt_f="29616">−1</offsets></sup><offsets xml_i="46709" xml_f="46710" txt_i="29616" txt_f="29617">
</offsets><italic><offsets xml_i="46718" xml_f="46719" txt_i="29617" txt_f="29618">P</offsets></italic><offsets xml_i="46728" xml_f="46745" txt_i="29618" txt_f="29635"> = 0.694) trials.</offsets></p></sec><sec><title><offsets xml_i="46767" xml_f="46789" txt_i="29637" txt_f="29659">Amino acid enrichments</offsets></title><p><offsets xml_i="46800" xml_f="46838" txt_i="29660" txt_f="29698">Muscle intracellular and blood plasma </offsets><sup><offsets xml_i="46843" xml_f="46845" txt_i="29698" txt_f="29700">13</offsets></sup><offsets xml_i="46851" xml_f="46852" txt_i="29700" txt_f="29701">C</offsets><sub><offsets xml_i="46857" xml_f="46858" txt_i="29701" txt_f="29702">6</offsets></sub><offsets xml_i="46864" xml_f="46988" txt_i="29702" txt_f="29826"> phenylalanine enrichments were stable over the measured time period of tracer incorporation (0–4 h) in both trials (Figure </offsets><xref ref-type="fig" rid="F3"><offsets xml_i="47018" xml_f="47019" txt_i="29826" txt_f="29827">3</offsets></xref><offsets xml_i="47026" xml_f="47036" txt_i="29827" txt_f="29837">). Plasma </offsets><sup><offsets xml_i="47041" xml_f="47043" txt_i="29837" txt_f="29839">13</offsets></sup><offsets xml_i="47049" xml_f="47050" txt_i="29839" txt_f="29840">C</offsets><sub><offsets xml_i="47055" xml_f="47056" txt_i="29840" txt_f="29841">6</offsets></sub><offsets xml_i="47062" xml_f="47228" txt_i="29841" txt_f="30007"> tyrosine enrichments increased over time during the experimental protocol (data not shown). Trial order had no effect on intracellular and plasma tracer enrichments.</offsets></p><fig id="F3" position="float"><label><offsets xml_i="47269" xml_f="47277" txt_i="30008" txt_f="30016">Figure 3</offsets></label><caption><p><offsets xml_i="47297" xml_f="47318" txt_i="30016" txt_f="30037">Muscle intracellular </offsets><bold><offsets xml_i="47324" xml_f="47327" txt_i="30037" txt_f="30040">(A)</offsets></bold><offsets xml_i="47334" xml_f="47346" txt_i="30040" txt_f="30052"> and plasma </offsets><bold><offsets xml_i="47352" xml_f="47355" txt_i="30052" txt_f="30055">(B)</offsets></bold><offsets xml_i="47362" xml_f="47363" txt_i="30055" txt_f="30056">
</offsets><sup><offsets xml_i="47368" xml_f="47370" txt_i="30056" txt_f="30058">13</offsets></sup><offsets xml_i="47376" xml_f="47377" txt_i="30058" txt_f="30059">C</offsets><sub><offsets xml_i="47382" xml_f="47383" txt_i="30059" txt_f="30060">6</offsets></sub><offsets xml_i="47389" xml_f="47618" txt_i="30060" txt_f="30289"> phenylalanine enrichments pre and post ingestion of either a branched-chain amino acid containing drink (BCAA, black circles) or placebo drink (PLA, white circles) following resistance exercise. Data are displayed as means ± SE.</offsets></p></caption><graphic xlink:href="fphys-08-00390-g0003"></graphic></fig></sec><sec><title><offsets xml_i="47709" xml_f="47742" txt_i="30291" txt_f="30324">Whole body phenylalanine kinetics</offsets></title><p><offsets xml_i="47753" xml_f="47848" txt_i="30325" txt_f="30420">Phenylalanine Ra, expressed as tAUC over the post drink period, was 6% lower in BCAA than PLA (</offsets><italic><offsets xml_i="47856" xml_f="47857" txt_i="30420" txt_f="30421">P</offsets></italic><offsets xml_i="47866" xml_f="47979" txt_i="30421" txt_f="30534"> = 0.028). In addition, tAUC of whole body phenylalanine oxidation rate was 16% lower in BCAA compared with PLA (</offsets><italic><offsets xml_i="47987" xml_f="47988" txt_i="30534" txt_f="30535">P</offsets></italic><offsets xml_i="47997" xml_f="48014" txt_i="30535" txt_f="30552"> = 0.006, Figure </offsets><xref ref-type="fig" rid="F4"><offsets xml_i="48044" xml_f="48045" txt_i="30552" txt_f="30553">4</offsets></xref><offsets xml_i="48052" xml_f="48054" txt_i="30553" txt_f="30555">).</offsets></p><fig id="F4" position="float"><label><offsets xml_i="48095" xml_f="48103" txt_i="30556" txt_f="30564">Figure 4</offsets></label><caption><p><offsets xml_i="48123" xml_f="48225" txt_i="30564" txt_f="30666">Phenylalanine kinetics, expressed as, total area under the curve for phenylalanine rate of appearance </offsets><bold><offsets xml_i="48231" xml_f="48234" txt_i="30666" txt_f="30669">(A)</offsets></bold><offsets xml_i="48241" xml_f="48301" txt_i="30669" txt_f="30729"> and total area under the curve for phenylalanine oxidation </offsets><bold><offsets xml_i="48307" xml_f="48310" txt_i="30729" txt_f="30732">(B)</offsets></bold><offsets xml_i="48317" xml_f="48476" txt_i="30732" txt_f="30891"> following the post-exercise ingestion of a branched-chain amino acid (BCAA, black bars) or placebo drink (PLA, white bars). Data are displayed as means ± SE. </offsets><sup><offsets xml_i="48481" xml_f="48482" txt_i="30891" txt_f="30892">*</offsets></sup><offsets xml_i="48488" xml_f="48530" txt_i="30892" txt_f="30934">Significant difference compared with PLA (</offsets><italic><offsets xml_i="48538" xml_f="48539" txt_i="30934" txt_f="30935">P</offsets></italic><offsets xml_i="48548" xml_f="48560" txt_i="30935" txt_f="30944"> &lt; 0.05).</offsets></p></caption><graphic xlink:href="fphys-08-00390-g0004"></graphic></fig></sec><sec><title><offsets xml_i="48651" xml_f="48678" txt_i="30946" txt_f="30973">Anabolic signaling proteins</offsets></title><p><offsets xml_i="48689" xml_f="48728" txt_i="30974" txt_f="31013">Signaling data are displayed in Figure </offsets><xref ref-type="fig" rid="F5"><offsets xml_i="48758" xml_f="48759" txt_i="31013" txt_f="31014">5</offsets></xref><offsets xml_i="48766" xml_f="48794" txt_i="31014" txt_f="31042">. The phosphorylation of AKT</offsets><sup><offsets xml_i="48799" xml_f="48805" txt_i="31042" txt_f="31048">Ser473</offsets></sup><offsets xml_i="48811" xml_f="48833" txt_i="31048" txt_f="31070"> increased over time (</offsets><italic><offsets xml_i="48841" xml_f="48842" txt_i="31070" txt_f="31071">P</offsets></italic><offsets xml_i="48851" xml_f="48898" txt_i="31071" txt_f="31118"> = 0.025). However, there was no trial effect (</offsets><italic><offsets xml_i="48906" xml_f="48907" txt_i="31118" txt_f="31119">P</offsets></italic><offsets xml_i="48916" xml_f="48953" txt_i="31119" txt_f="31156"> = 0.388). The phosphorylation of AKT</offsets><sup><offsets xml_i="48958" xml_f="48964" txt_i="31156" txt_f="31162">Ser473</offsets></sup><offsets xml_i="48970" xml_f="49015" txt_i="31162" txt_f="31207"> increased at 1 h compared with 0 h in BCAA (</offsets><italic><offsets xml_i="49023" xml_f="49024" txt_i="31207" txt_f="31208">P</offsets></italic><offsets xml_i="49033" xml_f="49075" txt_i="31208" txt_f="31250"> = 0.007). Further, phosphorylation of AKT</offsets><sup><offsets xml_i="49080" xml_f="49086" txt_i="31250" txt_f="31256">Ser473</offsets></sup><offsets xml_i="49092" xml_f="49138" txt_i="31256" txt_f="31302"> was higher at 1 h compared with 4 h in BCAA (</offsets><italic><offsets xml_i="49146" xml_f="49147" txt_i="31302" txt_f="31303">P</offsets></italic><offsets xml_i="49156" xml_f="49223" txt_i="31303" txt_f="31370"> = 0.015) but there were no differences between 0 and 4 h in BCAA (</offsets><italic><offsets xml_i="49231" xml_f="49232" txt_i="31370" txt_f="31371">P</offsets></italic><offsets xml_i="49241" xml_f="49297" txt_i="31371" txt_f="31427"> = 0.903). There were no differences between 0 and 1 h (</offsets><italic><offsets xml_i="49305" xml_f="49306" txt_i="31427" txt_f="31428">P</offsets></italic><offsets xml_i="49315" xml_f="49333" txt_i="31428" txt_f="31446"> = 0.056) or 4 h (</offsets><italic><offsets xml_i="49341" xml_f="49342" txt_i="31446" txt_f="31447">P</offsets></italic><offsets xml_i="49351" xml_f="49376" txt_i="31447" txt_f="31472"> = 0.174) and 1 and 4 h (</offsets><italic><offsets xml_i="49384" xml_f="49385" txt_i="31472" txt_f="31473">P</offsets></italic><offsets xml_i="49394" xml_f="49411" txt_i="31473" txt_f="31490"> = 0.085) in PLA.</offsets></p><fig id="F5" position="float"><label><offsets xml_i="49452" xml_f="49460" txt_i="31491" txt_f="31499">Figure 5</offsets></label><caption><p><offsets xml_i="49480" xml_f="49510" txt_i="31499" txt_f="31529">Phosphorylation status of, AKT</offsets><sup><offsets xml_i="49515" xml_f="49521" txt_i="31529" txt_f="31535">Ser473</offsets></sup><offsets xml_i="49527" xml_f="49528" txt_i="31535" txt_f="31536">
</offsets><bold><offsets xml_i="49534" xml_f="49537" txt_i="31536" txt_f="31539">(A)</offsets></bold><offsets xml_i="49544" xml_f="49552" txt_i="31539" txt_f="31547">, PRAS40</offsets><sup><offsets xml_i="49557" xml_f="49563" txt_i="31547" txt_f="31553">Thr246</offsets></sup><offsets xml_i="49569" xml_f="49570" txt_i="31553" txt_f="31554">
</offsets><bold><offsets xml_i="49576" xml_f="49579" txt_i="31554" txt_f="31557">(B)</offsets></bold><offsets xml_i="49586" xml_f="49592" txt_i="31557" txt_f="31563">, S6K1</offsets><sup><offsets xml_i="49597" xml_f="49603" txt_i="31563" txt_f="31569">Thr389</offsets></sup><offsets xml_i="49609" xml_f="49610" txt_i="31569" txt_f="31570">
</offsets><bold><offsets xml_i="49616" xml_f="49619" txt_i="31570" txt_f="31573">(C)</offsets></bold><offsets xml_i="49626" xml_f="49637" txt_i="31573" txt_f="31584">, and 4EBP1</offsets><sup><offsets xml_i="49642" xml_f="49650" txt_i="31584" txt_f="31592">Thr37/45</offsets></sup><offsets xml_i="49656" xml_f="49657" txt_i="31592" txt_f="31593">
</offsets><bold><offsets xml_i="49663" xml_f="49666" txt_i="31593" txt_f="31596">(D)</offsets></bold><offsets xml_i="49673" xml_f="49898" txt_i="31596" txt_f="31821"> immediately pre (0 h), 1-, and 4 h-post ingestion of either a branched-chain amino acid containing drink (BCAA, black bars) or placebo drink (PLA, white bars) following resistance exercise. Data are displayed as means ± SE. </offsets><sup><offsets xml_i="49903" xml_f="49904" txt_i="31821" txt_f="31822">#</offsets></sup><offsets xml_i="49910" xml_f="49964" txt_i="31822" txt_f="31876">Significant difference from 0 h in respective trials (</offsets><italic><offsets xml_i="49972" xml_f="49973" txt_i="31876" txt_f="31877">P</offsets></italic><offsets xml_i="49982" xml_f="49994" txt_i="31877" txt_f="31886"> &lt; 0.05).</offsets></p></caption><graphic xlink:href="fphys-08-00390-g0005"></graphic></fig><p><offsets xml_i="50070" xml_f="50099" txt_i="31887" txt_f="31916">The phosphorylation of PRAS40</offsets><sup><offsets xml_i="50104" xml_f="50110" txt_i="31916" txt_f="31922">Thr246</offsets></sup><offsets xml_i="50116" xml_f="50138" txt_i="31922" txt_f="31944"> increased over time (</offsets><italic><offsets xml_i="50146" xml_f="50147" txt_i="31944" txt_f="31945">P</offsets></italic><offsets xml_i="50156" xml_f="50203" txt_i="31945" txt_f="31992"> = 0.022). However, there was no trial effect (</offsets><italic><offsets xml_i="50211" xml_f="50212" txt_i="31992" txt_f="31993">P</offsets></italic><offsets xml_i="50221" xml_f="50261" txt_i="31993" txt_f="32033"> = 0.281). The phosphorylation of PRAS40</offsets><sup><offsets xml_i="50266" xml_f="50272" txt_i="32033" txt_f="32039">Thr246</offsets></sup><offsets xml_i="50278" xml_f="50332" txt_i="32039" txt_f="32093"> increased ~12-fold at 1 h compared with 0 h in BCAA (</offsets><italic><offsets xml_i="50340" xml_f="50341" txt_i="32093" txt_f="32094">P</offsets></italic><offsets xml_i="50350" xml_f="50394" txt_i="32094" txt_f="32138"> = 0.037). Further phosphorylation of PRAS40</offsets><sup><offsets xml_i="50399" xml_f="50405" txt_i="32138" txt_f="32144">Thr246</offsets></sup><offsets xml_i="50411" xml_f="50457" txt_i="32144" txt_f="32190"> was higher at 1 h compared with 4 h in BCAA (</offsets><italic><offsets xml_i="50465" xml_f="50466" txt_i="32190" txt_f="32191">P</offsets></italic><offsets xml_i="50475" xml_f="50542" txt_i="32191" txt_f="32258"> = 0.047) but there were no differences between 0 and 4 h in BCAA (</offsets><italic><offsets xml_i="50550" xml_f="50551" txt_i="32258" txt_f="32259">P</offsets></italic><offsets xml_i="50560" xml_f="50616" txt_i="32259" txt_f="32315"> = 0.102). There were no differences between 0 and 1 h (</offsets><italic><offsets xml_i="50624" xml_f="50625" txt_i="32315" txt_f="32316">P</offsets></italic><offsets xml_i="50634" xml_f="50652" txt_i="32316" txt_f="32334"> = 0.050) or 4 h (</offsets><italic><offsets xml_i="50660" xml_f="50661" txt_i="32334" txt_f="32335">P</offsets></italic><offsets xml_i="50670" xml_f="50695" txt_i="32335" txt_f="32360"> = 0.101) and 1 and 4 h (</offsets><italic><offsets xml_i="50703" xml_f="50704" txt_i="32360" txt_f="32361">P</offsets></italic><offsets xml_i="50713" xml_f="50730" txt_i="32361" txt_f="32378"> = 0.112) in PLA.</offsets></p><p><offsets xml_i="50737" xml_f="50764" txt_i="32379" txt_f="32406">The phosphorylation of S6K1</offsets><sup><offsets xml_i="50769" xml_f="50775" txt_i="32406" txt_f="32412">Thr389</offsets></sup><offsets xml_i="50781" xml_f="50803" txt_i="32412" txt_f="32434"> increased over time (</offsets><italic><offsets xml_i="50811" xml_f="50812" txt_i="32434" txt_f="32435">P</offsets></italic><offsets xml_i="50821" xml_f="50868" txt_i="32435" txt_f="32482"> = 0.021). However, there was no trial effect (</offsets><italic><offsets xml_i="50876" xml_f="50877" txt_i="32482" txt_f="32483">P</offsets></italic><offsets xml_i="50886" xml_f="50924" txt_i="32483" txt_f="32521"> = 0.087). The phosphorylation of S6K1</offsets><sup><offsets xml_i="50929" xml_f="50935" txt_i="32521" txt_f="32527">Thr389</offsets></sup><offsets xml_i="50941" xml_f="50994" txt_i="32527" txt_f="32580"> increased ~6-fold at 1 h compared with 0 h in BCAA (</offsets><italic><offsets xml_i="51002" xml_f="51003" txt_i="32580" txt_f="32581">P</offsets></italic><offsets xml_i="51012" xml_f="51055" txt_i="32581" txt_f="32624"> = 0.017). Further, phosphorylation of S6K1</offsets><sup><offsets xml_i="51060" xml_f="51066" txt_i="32624" txt_f="32630">Thr389</offsets></sup><offsets xml_i="51072" xml_f="51118" txt_i="32630" txt_f="32676"> was higher at 1 h compared with 4 h in BCAA (</offsets><italic><offsets xml_i="51126" xml_f="51127" txt_i="32676" txt_f="32677">P</offsets></italic><offsets xml_i="51136" xml_f="51203" txt_i="32677" txt_f="32744"> = 0.014) but there were no differences between 1 and 4 h in BCAA (</offsets><italic><offsets xml_i="51211" xml_f="51212" txt_i="32744" txt_f="32745">P</offsets></italic><offsets xml_i="51221" xml_f="51277" txt_i="32745" txt_f="32801"> = 0.690). There were no differences between 0 and 1 h (</offsets><italic><offsets xml_i="51285" xml_f="51286" txt_i="32801" txt_f="32802">P</offsets></italic><offsets xml_i="51295" xml_f="51313" txt_i="32802" txt_f="32820"> = 0.120) or 4 h (</offsets><italic><offsets xml_i="51321" xml_f="51322" txt_i="32820" txt_f="32821">P</offsets></italic><offsets xml_i="51331" xml_f="51356" txt_i="32821" txt_f="32846"> = 0.05)0 and 1 and 4 h (</offsets><italic><offsets xml_i="51364" xml_f="51365" txt_i="32846" txt_f="32847">P</offsets></italic><offsets xml_i="51374" xml_f="51391" txt_i="32847" txt_f="32864"> = 0.795) in PLA.</offsets></p><p><offsets xml_i="51398" xml_f="51426" txt_i="32865" txt_f="32893">The phosphorylation of 4EBP1</offsets><sup><offsets xml_i="51431" xml_f="51439" txt_i="32893" txt_f="32901">Thr37/45</offsets></sup><offsets xml_i="51445" xml_f="51475" txt_i="32901" txt_f="32931"> remained constant over time (</offsets><italic><offsets xml_i="51483" xml_f="51484" txt_i="32931" txt_f="32932">P</offsets></italic><offsets xml_i="51493" xml_f="51535" txt_i="32932" txt_f="32974"> = 0.115) and there were no trial effect (</offsets><italic><offsets xml_i="51543" xml_f="51544" txt_i="32974" txt_f="32975">P</offsets></italic><offsets xml_i="51553" xml_f="51563" txt_i="32975" txt_f="32985"> = 0.566).</offsets></p></sec><sec><title><offsets xml_i="51585" xml_f="51622" txt_i="32987" txt_f="33024">Muscle myofibrillar protein synthesis</offsets></title><p><offsets xml_i="51633" xml_f="51667" txt_i="33025" txt_f="33059">Myofibrillar FSR was ~22% higher (</offsets><italic><offsets xml_i="51675" xml_f="51676" txt_i="33059" txt_f="33060">P</offsets></italic><offsets xml_i="51685" xml_f="51766" txt_i="33060" txt_f="33141"> = 0.012) in BCAA than PLA over the 4 h period following drink ingestion (Figure </offsets><xref ref-type="fig" rid="F6"><offsets xml_i="51796" xml_f="51797" txt_i="33141" txt_f="33142">6</offsets></xref><offsets xml_i="51804" xml_f="51806" txt_i="33142" txt_f="33144">).</offsets></p><fig id="F6" position="float"><label><offsets xml_i="51847" xml_f="51855" txt_i="33145" txt_f="33153">Figure 6</offsets></label><caption><p><offsets xml_i="51875" xml_f="52116" txt_i="33153" txt_f="33394">Muscle myofibrillar fractional synthesis rate following the post-exercise ingestion of a branched-chain amino acid containing drink (BCAA) or placebo drink (PLA). Data are displayed as means (bars) and individual responses (dots and lines). </offsets><sup><offsets xml_i="52121" xml_f="52122" txt_i="33394" txt_f="33395">*</offsets></sup><offsets xml_i="52128" xml_f="52170" txt_i="33395" txt_f="33437">Significant difference compared with PLA (</offsets><italic><offsets xml_i="52178" xml_f="52179" txt_i="33437" txt_f="33438">P</offsets></italic><offsets xml_i="52188" xml_f="52200" txt_i="33438" txt_f="33447"> &lt; 0.05).</offsets></p></caption><graphic xlink:href="fphys-08-00390-g0006"></graphic></fig></sec></sec><sec sec-type="discussion" id="s4"><title><offsets xml_i="52327" xml_f="52337" txt_i="33450" txt_f="33460">Discussion</offsets></title><p><offsets xml_i="52348" xml_f="52818" txt_i="33461" txt_f="33931">The present study demonstrated that ingesting of all three BCAAs alone, without concurrent ingestion of other EAA, protein, or macronutrients, stimulated a 22% greater response of myofibrillar-MPS following resistance exercise compared with a placebo. The magnitude of this increased response of myofibrillar-MPS was ~50% less than the previously reported myofibrillar-MPS response to a dose of whey protein containing similar amounts of BCAAs (Churchward-Venne et al., </offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="52850" xml_f="52854" txt_i="33931" txt_f="33935">2012</offsets></xref><offsets xml_i="52861" xml_f="52878" txt_i="33935" txt_f="33952">; Witard et al., </offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="52910" xml_f="52914" txt_i="33952" txt_f="33956">2014</offsets></xref><offsets xml_i="52921" xml_f="53426" txt_i="33956" txt_f="34461">). Taken together, these results demonstrate that BCAAs exhibit the capacity to stimulate myofibrillar-MPS, however a full complement of EAA could be necessary to stimulate a maximal response of myofibrillar-MPS following resistance exercise. This information potentially has important nutritional implications for selecting amino acid supplements to facilitate skeletal muscle hypertrophy in response to resistance exercise training and the maintenance of muscle mass during aging, unloading, or disease.</offsets></p><p><offsets xml_i="53433" xml_f="53851" txt_i="34462" txt_f="34880">The most likely physiological explanation for the apparent attenuation of the post-exercise response of myofibrillar-MPS to BCAA ingestion in comparison to an intact protein source relates to the limited availability of amino acids as substrate for MPS. It is well-established that BCAA ingestion stimulates the activation of mTORC1 signaling pathways that regulate the translational activity of MPS (Karlsson et al., </offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="53883" xml_f="53887" txt_i="34880" txt_f="34884">2004</offsets></xref><offsets xml_i="53894" xml_f="53917" txt_i="34884" txt_f="34907">; Apro and Blomstrand, </offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="53948" xml_f="53952" txt_i="34907" txt_f="34911">2010</offsets></xref><offsets xml_i="53959" xml_f="53976" txt_i="34911" txt_f="34928">; Moberg et al., </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="54008" xml_f="54012" txt_i="34928" txt_f="34932">2016</offsets></xref><offsets xml_i="54019" xml_f="54165" txt_i="34932" txt_f="35078">). Moreover, recent results demonstrate that the presence of the valine and isoleucine enhances the response of mTORC1 to leucine (Moberg et al., </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="54197" xml_f="54201" txt_i="35078" txt_f="35082">2016</offsets></xref><offsets xml_i="54208" xml_f="54677" txt_i="35082" txt_f="35551">). However, results from the present study suggest that ingesting BCAAs alone, without the other EAA, provides limited substrate for protein synthesis in exercised muscles. Thus, the overall response of MPS is not maximized. Instead, the limited availability of EAA likely explains the qualitative difference in magnitude of the MPS response to ingestion of BCAAs alone and ingestion of similar amounts of BCAAs as part of intact whey protein (Churchward-Venne et al., </offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="54709" xml_f="54713" txt_i="35551" txt_f="35555">2012</offsets></xref><offsets xml_i="54720" xml_f="54722" txt_i="35555" txt_f="35557">, </offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="54754" xml_f="54758" txt_i="35557" txt_f="35561">2014</offsets></xref><offsets xml_i="54765" xml_f="54782" txt_i="35561" txt_f="35578">; Witard et al., </offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="54814" xml_f="54818" txt_i="35578" txt_f="35582">2014</offsets></xref><offsets xml_i="54825" xml_f="55117" txt_i="35582" txt_f="35874">). Moreover, in the present study, we observed a decline in arterialized phenylalanine concentrations 3 h after drink ingestion in the BCAA trial. This finding is consistent with previous research that observed decreased EAA concentrations following leucine ingestion (Hagenfeldt and Wahren, </offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="55149" xml_f="55153" txt_i="35874" txt_f="35878">1980</offsets></xref><offsets xml_i="55160" xml_f="55175" txt_i="35878" txt_f="35893">; Nair et al., </offsets><xref rid="B32" ref-type="bibr"><offsets xml_i="55207" xml_f="55211" txt_i="35893" txt_f="35897">1992</offsets></xref><offsets xml_i="55218" xml_f="55235" txt_i="35897" txt_f="35914">; Tipton et al., </offsets><xref rid="B38" ref-type="bibr"><offsets xml_i="55267" xml_f="55271" txt_i="35914" txt_f="35918">2009</offsets></xref><offsets xml_i="55278" xml_f="55298" txt_i="35918" txt_f="35938">; Borgenvik et al., </offsets><xref rid="B8" ref-type="bibr"><offsets xml_i="55329" xml_f="55333" txt_i="35938" txt_f="35942">2012</offsets></xref><offsets xml_i="55340" xml_f="55521" txt_i="35942" txt_f="36123">). Taken together, these data support the notion that EAA availability is the rate-limiting factor for stimulating a maximal MPS response to resistance exercise with BCAA ingestion.</offsets></p><p><offsets xml_i="55528" xml_f="55909" txt_i="36124" txt_f="36505">The decline in EAA availability that we observed with BCAA ingestion also provides a potential physiological explanation for the differential response of MPS to ingesting a BCAA source at rest and following resistance exercise. Previously, Wilkinson and colleagues reported an ~100% increase in myofibrillar-MPS in response to ingestion of leucine alone at rest (Wilkinson et al., </offsets><xref rid="B45" ref-type="bibr"><offsets xml_i="55941" xml_f="55945" txt_i="36505" txt_f="36509">2013</offsets></xref><offsets xml_i="55952" xml_f="56426" txt_i="36509" txt_f="36983">). Furthermore, a study from Churchward-Venne and colleagues reported that adding leucine to a “suboptimal” dose (6.25 g) of whey protein resulted in rates of myofibrillar-MPS similar to those after ingestion of 25 g of whey protein at rest. However, consistent with the results reported in the present study, the addition of leucine to 6.25 g of whey protein was not as effective as higher doses of whey protein ingested after resistance exercise (Churchward-Venne et al., </offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="56458" xml_f="56462" txt_i="36983" txt_f="36987">2012</offsets></xref><offsets xml_i="56469" xml_f="56702" txt_i="36987" txt_f="37220">). Thus, exercise has been shown to alter the relationship of the MPS response to ingested leucine and intact protein. It is likely that the enhanced ability of muscle to utilize ingested protein following exercise (Pennings et al., </offsets><xref rid="B34" ref-type="bibr"><offsets xml_i="56734" xml_f="56738" txt_i="37220" txt_f="37224">2011</offsets></xref><offsets xml_i="56745" xml_f="56762" txt_i="37224" txt_f="37241">; Witard et al., </offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="56794" xml_f="56798" txt_i="37241" txt_f="37245">2014</offsets></xref><offsets xml_i="56805" xml_f="56957" txt_i="37245" txt_f="37397">) leads to a greater demand for EAA, thus resulting in limited EAA availability at the greater rates of MPS. In another study, Churchward-Venne et al. (</offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="56989" xml_f="56993" txt_i="37397" txt_f="37401">2014</offsets></xref><offsets xml_i="57000" xml_f="57358" txt_i="37401" txt_f="37759">) also reported that BCAA added to a suboptimal dose of whey protein resulted in less stimulation of MPS than when the same amount of leucine alone was added to suboptimal whey protein. These data suggest that leucine alone may be sufficient to stimulate MPS following exercise provided a minimal amount of EAA is included. However, Churchward-Venne et al. (</offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="57390" xml_f="57394" txt_i="37759" txt_f="37763">2014</offsets></xref><offsets xml_i="57401" xml_f="57666" txt_i="37763" txt_f="38028">) included ingestion of leucine with 6.25 g of whey protein and a mixed macronutrient beverage making direct comparisons with our results difficult. Leucine seems to be the most important BCAA for stimulation of the translation initiation pathways (Anthony et al., </offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="57697" xml_f="57701" txt_i="38028" txt_f="38032">2000</offsets></xref><offsets xml_i="57708" xml_f="57726" txt_i="38032" txt_f="38050">; Crozier et al., </offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="57758" xml_f="57762" txt_i="38050" txt_f="38054">2005</offsets></xref><offsets xml_i="57769" xml_f="57831" txt_i="38054" txt_f="38116">) and leucine alone stimulates MPS at rest (Wilkinson et al., </offsets><xref rid="B45" ref-type="bibr"><offsets xml_i="57863" xml_f="57867" txt_i="38116" txt_f="38120">2013</offsets></xref><offsets xml_i="57874" xml_f="58142" txt_i="38120" txt_f="38388">). Thus, it is possible that leucine is solely responsible for the stimulation in MPS we report here. On the other hand, recent data suggest that there is a greater stimulatory effect on mTORC1 when valine and isoleucine are consumed alongside leucine (Moberg et al., </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="58174" xml_f="58178" txt_i="38388" txt_f="38392">2016</offsets></xref><offsets xml_i="58185" xml_f="58562" txt_i="38392" txt_f="38769">). Nevertheless, taken together, these past and present data suggest that the availability of EAA may be a critical factor for the optimal response of MPS following resistance exercise. Since the ingestion of BCAAs alone stimulates myofibrillar-MPS, but does not increase the supply of all EAA, the overall response of myofibrillar-MPS following resistance exercise is limited.</offsets></p><p><offsets xml_i="58569" xml_f="58771" txt_i="38770" txt_f="38972">The influence of exogenous BCAAs on the stimulation of MPS following exercise is mediated by an increased activation of the mTORC1-S6K1 signaling pathway. In the present study, the stimulation of PRAS40</offsets><sup><offsets xml_i="58776" xml_f="58782" txt_i="38972" txt_f="38978">Thr246</offsets></sup><offsets xml_i="58788" xml_f="58798" txt_i="38978" txt_f="38988">, and S6K1</offsets><sup><offsets xml_i="58803" xml_f="58809" txt_i="38988" txt_f="38994">Thr389</offsets></sup><offsets xml_i="58815" xml_f="59036" txt_i="38994" txt_f="39215"> phosphorylation 1 h following drink ingestion was higher in BCAA than PLA. Thus, our results are consistent with earlier work demonstrating an upregulation of translational activity with BCAA ingestion (Karlsson et al., </offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="59068" xml_f="59072" txt_i="39215" txt_f="39219">2004</offsets></xref><offsets xml_i="59079" xml_f="59102" txt_i="39219" txt_f="39242">; Apro and Blomstrand, </offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="59133" xml_f="59137" txt_i="39242" txt_f="39246">2010</offsets></xref><offsets xml_i="59144" xml_f="59338" txt_i="39246" txt_f="39440">). The present study is the first to demonstrate the upregulation of mTORC1 signaling with BCAA ingestion translates into an increased response of myofibrillar-MPS following resistance exercise.</offsets></p><p><offsets xml_i="59345" xml_f="59448" txt_i="39441" txt_f="39544">BCAAs has been shown to influence muscle protein metabolism through MPB as well as MPS (Buse and Reid, </offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="59479" xml_f="59483" txt_i="39544" txt_f="39548">1975</offsets></xref><offsets xml_i="59490" xml_f="59507" txt_i="39548" txt_f="39565">; Louard et al., </offsets><xref rid="B24" ref-type="bibr"><offsets xml_i="59539" xml_f="59543" txt_i="39565" txt_f="39569">1990</offsets></xref><offsets xml_i="59550" xml_f="59570" txt_i="39569" txt_f="39589">; Wilkinson et al., </offsets><xref rid="B45" ref-type="bibr"><offsets xml_i="59602" xml_f="59606" txt_i="39589" txt_f="39593">2013</offsets></xref><offsets xml_i="59613" xml_f="59708" txt_i="39593" txt_f="39688">). Early studies demonstrated that BCAAs reduce whole-body protein breakdown (Ferrando et al., </offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="59740" xml_f="59744" txt_i="39688" txt_f="39692">1995</offsets></xref><offsets xml_i="59751" xml_f="59777" txt_i="39692" txt_f="39718">) and MPB (Louard et al., </offsets><xref rid="B24" ref-type="bibr"><offsets xml_i="59809" xml_f="59813" txt_i="39718" txt_f="39722">1990</offsets></xref><offsets xml_i="59820" xml_f="59835" txt_i="39722" txt_f="39737">; Nair et al., </offsets><xref rid="B32" ref-type="bibr"><offsets xml_i="59867" xml_f="59871" txt_i="39737" txt_f="39741">1992</offsets></xref><offsets xml_i="59878" xml_f="60022" txt_i="39741" txt_f="39885">). Recent evidence suggests the impact of BCAAs on MPB may be mediated by the leucine metabolite, β-hydroxy-β-methylbutyrate (Wilkinson et al., </offsets><xref rid="B45" ref-type="bibr"><offsets xml_i="60054" xml_f="60058" txt_i="39885" txt_f="39889">2013</offsets></xref><offsets xml_i="60065" xml_f="60721" txt_i="39889" txt_f="40545">). However, to date no study has investigated the impact of BCAA supplementation on MPB following exercise. Unfortunately, it was not possible to directly measure MPB in the present study, however our data suggest that whole-body protein breakdown was reduced by BCAA ingestion. Whereas, urea production rates were similar between trials, phenylalanine Ra, and phenylalanine oxidation rates—both indicators of whole body protein catabolism—were lower in BCAA than PLA during the 4 h period after drink ingestion. These data are consistent with previously reported results following ingestion of intact protein with similar amounts of BCAAs (Witard et al., </offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="60753" xml_f="60757" txt_i="40545" txt_f="40549">2014</offsets></xref><offsets xml_i="60764" xml_f="60864" txt_i="40549" txt_f="40649">). It has been reported that MPB is reduced by insulin following resistance exercise (Biolo et al., </offsets><xref rid="B6" ref-type="bibr"><offsets xml_i="60895" xml_f="60899" txt_i="40649" txt_f="40653">1999</offsets></xref><offsets xml_i="60906" xml_f="61309" txt_i="40653" txt_f="41056">). However, the insulin response to BCAA and PLA was similar, so it is unlikely that insulin explains the decline in whole-body protein breakdown following BCAA ingestion. Thus, it seems clear that whole-body protein breakdown is decreased, albeit minimally, with ingestion of BCAAs following resistance exercise. However, these results do not necessarily mean that MPB is decreased with BCAA ingestion.</offsets></p><p><offsets xml_i="61316" xml_f="62105" txt_i="41057" txt_f="41846">To conclude, the ingestion of BCAAs alone, without the concurrent ingestion of other EAA, intact protein or other macronutrients, increases the stimulation of mTORC1 activity and myofibrillar-MPS following exercise in resistance-trained young men. Our data support the notion that BCAA ingestion alone does not maximally stimulate myofibrillar-MPS following exercise despite stimulation of translation initiation pathways. The lack of sufficient EAA appears to limit the response of myofibrillar-MPS following exercise. Thus, whereas our data clearly show that BCAA ingestion activates cell-signaling pathways that result in increased myofibrillar-MPS, ingestion of BCAAs alone may not be the optimal nutritional regimen to stimulate a maximal MPS response to resistance exercise training.</offsets></p></sec><sec id="s5"><title><offsets xml_i="62135" xml_f="62155" txt_i="41848" txt_f="41868">Author contributions</offsets></title><p><offsets xml_i="62166" xml_f="62482" txt_i="41869" txt_f="42185">SRJ, OCW, GAW, and KDT designed the research project and conducted the research; SRJ, OCW, and KDT had primary responsibility for the final content of the manuscript and wrote the manuscript; SRJ, OCW, AP, and KB analyzed data or performed statistical analysis and all authors read and approved the final manuscript.</offsets></p><sec><title><offsets xml_i="62498" xml_f="62528" txt_i="42186" txt_f="42216">Conflict of interest statement</offsets></title><p><offsets xml_i="62539" xml_f="62711" txt_i="42217" txt_f="42389">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</offsets></p></sec></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> Supported by GlaxoSmithKline Healthcare (research grant to KDT).</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>J. C.</given-names></name><name><surname>Anthony</surname><given-names>T. G.</given-names></name><name><surname>Kimball</surname><given-names>S. R.</given-names></name><name><surname>Vary</surname><given-names>T. C.</given-names></name><name><surname>Jefferson</surname><given-names>L. S.</given-names></name></person-group> (<year>2000</year>). <article-title></article-title>. <source>J. Nutr.</source>
<volume>130</volume>, <fpage>139</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="pmid">10720160</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>J. C.</given-names></name><name><surname>Anthony</surname><given-names>T. G.</given-names></name><name><surname>Layman</surname><given-names>D. K.</given-names></name></person-group> (<year>1999</year>). <article-title>Leucine supplementation enhances skeletal muscle recovery in rats following exercise</article-title>. <source>J. Nutr.</source>
<volume>129</volume>, <fpage>1102</fpage>–<lpage>1106</lpage>. <pub-id pub-id-type="pmid">10356072</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apro</surname><given-names>W.</given-names></name><name><surname>Blomstrand</surname><given-names>E.</given-names></name></person-group> (<year>2010</year>). <article-title>Influence of supplementation with branched-chain amino acids in combination with resistance exercise on p70S6 kinase phosphorylation in resting and exercising human skeletal muscle</article-title>. <source>Acta Physiol. (Oxf)</source>
<volume>200</volume>, <fpage>237</fpage>–<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-1716.2010.02151.x</pub-id><pub-id pub-id-type="pmid">20528801</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atherton</surname><given-names>P. J.</given-names></name><name><surname>Etheridge</surname><given-names>T.</given-names></name><name><surname>Watt</surname><given-names>P. W.</given-names></name><name><surname>Wilkinson</surname><given-names>D.</given-names></name><name><surname>Selby</surname><given-names>A.</given-names></name><name><surname>Rankin</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2010a</year>). <article-title>Muscle full effect after oral protein: time-dependent concordance and discordance between human muscle protein synthesis and mTORC1 signaling</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>92</volume>, <fpage>1080</fpage>–<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.2010.29819</pub-id><pub-id pub-id-type="pmid">20844073</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atherton</surname><given-names>P. J.</given-names></name><name><surname>Smith</surname><given-names>K.</given-names></name><name><surname>Etheridge</surname><given-names>T.</given-names></name><name><surname>Rankin</surname><given-names>D.</given-names></name><name><surname>Rennie</surname><given-names>M. J.</given-names></name></person-group> (<year>2010b</year>). <article-title>Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells</article-title>. <source>Amino Acids</source>
<volume>38</volume>, <fpage>1533</fpage>–<lpage>1539</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-009-0377-x</pub-id><pub-id pub-id-type="pmid">19882215</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biolo</surname><given-names>G.</given-names></name><name><surname>Williams</surname><given-names>B. D.</given-names></name><name><surname>Fleming</surname><given-names>R. Y.</given-names></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name></person-group> (<year>1999</year>). <article-title>Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise</article-title>. <source>Diabetes</source>
<volume>48</volume>, <fpage>949</fpage>–<lpage>957</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.48.5.949</pub-id><pub-id pub-id-type="pmid">10331397</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>G. A.</given-names></name></person-group> (<year>1973</year>). <article-title>Perceived exertion: a note on “history” and methods</article-title>. <source>Med. Sci. Sports</source>
<volume>5</volume>, <fpage>90</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1249/00005768-197300520-00017</pub-id><pub-id pub-id-type="pmid">4721012</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgenvik</surname><given-names>M.</given-names></name><name><surname>Apro</surname><given-names>W.</given-names></name><name><surname>Blomstrand</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Intake of branched-chain amino acids influences the levels of MAFbx mRNA and MuRF-1 total protein in resting and exercising human muscle</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source>
<volume>302</volume>, <fpage>E510</fpage>–<lpage>E521</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00353.2011</pub-id><pub-id pub-id-type="pmid">22127230</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buse</surname><given-names>M. G.</given-names></name><name><surname>Reid</surname><given-names>S. S.</given-names></name></person-group> (<year>1975</year>). <article-title>Leucine. A possible regulator of protein turnover in muscle</article-title>. <source>J. Clin. Invest.</source>
<volume>56</volume>, <fpage>1250</fpage>–<lpage>1261</lpage>. <pub-id pub-id-type="doi">10.1172/JCI108201</pub-id><pub-id pub-id-type="pmid">1237498</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churchward-Venne</surname><given-names>T. A.</given-names></name><name><surname>Breen</surname><given-names>L.</given-names></name><name><surname>Di Donato</surname><given-names>D. M.</given-names></name><name><surname>Hector</surname><given-names>A. J.</given-names></name><name><surname>Mitchell</surname><given-names>C. J.</given-names></name><name><surname>Moore</surname><given-names>D. R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Leucine supplementation of a low-protein mixed macronutrient beverage enhances myofibrillar protein synthesis in young men: a double-blind, randomized trial</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>99</volume>, <fpage>276</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.113.068775</pub-id><pub-id pub-id-type="pmid">24284442</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churchward-Venne</surname><given-names>T. A.</given-names></name><name><surname>Burd</surname><given-names>N. A.</given-names></name><name><surname>Mitchell</surname><given-names>C. J.</given-names></name><name><surname>West</surname><given-names>D. W.</given-names></name><name><surname>Philp</surname><given-names>A.</given-names></name><name><surname>Marcotte</surname><given-names>G. R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Supplementation of a suboptimal protein dose with leucine or essential amino acids: effects on myofibrillar protein synthesis at rest and following resistance exercise in men</article-title>. <source>J. Physiol.</source>
<volume>590</volume>, <fpage>2751</fpage>–<lpage>2765</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2012.228833</pub-id><pub-id pub-id-type="pmid">22451437</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crozier</surname><given-names>S. J.</given-names></name><name><surname>Kimball</surname><given-names>S. R.</given-names></name><name><surname>Emmert</surname><given-names>S. W.</given-names></name><name><surname>Anthony</surname><given-names>J. C.</given-names></name><name><surname>Jefferson</surname><given-names>L. S.</given-names></name></person-group> (<year>2005</year>). <article-title>Oral leucine administration stimulates protein synthesis in rat skeletal muscle</article-title>. <source>J. Nutr.</source>
<volume>135</volume>, <fpage>376</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="pmid">15735066</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreyer</surname><given-names>H. C.</given-names></name><name><surname>Drummond</surname><given-names>M. J.</given-names></name><name><surname>Pennings</surname><given-names>B.</given-names></name><name><surname>Fujita</surname><given-names>S.</given-names></name><name><surname>Glynn</surname><given-names>E. L.</given-names></name><name><surname>Chinkes</surname><given-names>D. L.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source>
<volume>294</volume>, <fpage>E392</fpage>–<lpage>E400</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00582.2007</pub-id><pub-id pub-id-type="pmid">18056791</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrando</surname><given-names>A. A.</given-names></name><name><surname>Williams</surname><given-names>B. D.</given-names></name><name><surname>Stuart</surname><given-names>C. A.</given-names></name><name><surname>Lane</surname><given-names>H. W.</given-names></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name></person-group> (<year>1995</year>). <article-title>Oral branched-chain amino acids decrease whole-body proteolysis</article-title>. <source>JPEN J. Parenter. Enteral Nutr.</source>
<volume>19</volume>, <fpage>47</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1177/014860719501900147</pub-id><pub-id pub-id-type="pmid">7658600</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glynn</surname><given-names>E. L.</given-names></name><name><surname>Fry</surname><given-names>C. S.</given-names></name><name><surname>Drummond</surname><given-names>M. J.</given-names></name><name><surname>Timmerman</surname><given-names>K. L.</given-names></name><name><surname>Dhanani</surname><given-names>S.</given-names></name><name><surname>Volpi</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Excess leucine intake enhances muscle anabolic signaling but not net protein anabolism in young men and women</article-title>. <source>J. Nutr.</source>
<volume>140</volume>, <fpage>1970</fpage>–<lpage>1976</lpage>. <pub-id pub-id-type="doi">10.3945/jn.110.127647</pub-id><pub-id pub-id-type="pmid">20844186</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagenfeldt</surname><given-names>L.</given-names></name><name><surname>Wahren</surname><given-names>J.</given-names></name></person-group> (<year>1980</year>). <article-title>Experimental studies on the metabolic effects of branched chain amino acids</article-title>. <source>Acta Chir. Scand. Suppl.</source>
<volume>498</volume>, <fpage>88</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="pmid">6776744</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahoor</surname><given-names>F.</given-names></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name></person-group> (<year>1987</year>). <article-title>Reassessment of primed constant-infusion tracer method to measure urea kinetics</article-title>. <source>Am. J. Physiol.</source>
<volume>252</volume>, <fpage>E557</fpage>–<lpage>E564</lpage>. <pub-id pub-id-type="pmid">3565564</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>H. K.</given-names></name><name><surname>Nilsson</surname><given-names>P. A.</given-names></name><name><surname>Nilsson</surname><given-names>J.</given-names></name><name><surname>Chibalin</surname><given-names>A. V.</given-names></name><name><surname>Zierath</surname><given-names>J. R.</given-names></name><name><surname>Blomstrand</surname><given-names>E.</given-names></name></person-group> (<year>2004</year>). <article-title>Branched-chain amino acids increase p70S6k phosphorylation in human skeletal muscle after resistance exercise</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source>
<volume>287</volume>, <fpage>E1</fpage>–<lpage>E7</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00430.2003</pub-id><pub-id pub-id-type="pmid">14998784</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimball</surname><given-names>S. R.</given-names></name><name><surname>Jefferson</surname><given-names>L. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis</article-title>. <source>J. Nutr.</source>
<volume>136</volume>, <fpage>227S</fpage>–<lpage>231S</lpage>. <pub-id pub-id-type="pmid">16365087</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopman</surname><given-names>R.</given-names></name><name><surname>Verdijk</surname><given-names>L. B.</given-names></name><name><surname>Beelen</surname><given-names>M.</given-names></name><name><surname>Gorselink</surname><given-names>M.</given-names></name><name><surname>Kruseman</surname><given-names>A. N.</given-names></name><name><surname>Wagenmakers</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Co-ingestion of leucine with protein does not further augment post-exercise muscle protein synthesis rates in elderly men</article-title>. <source>Br. J. Nutr.</source>
<volume>99</volume>, <fpage>571</fpage>–<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114507812013</pub-id><pub-id pub-id-type="pmid">17697406</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopman</surname><given-names>R.</given-names></name><name><surname>Verdijk</surname><given-names>L.</given-names></name><name><surname>Manders</surname><given-names>R. J.</given-names></name><name><surname>Gijsen</surname><given-names>A. P.</given-names></name><name><surname>Gorselink</surname><given-names>M.</given-names></name><name><surname>Pijpers</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Co-ingestion of protein and leucine stimulates muscle protein synthesis rates to the same extent in young and elderly lean men</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>84</volume>, <fpage>623</fpage>–<lpage>632</lpage>. <pub-id pub-id-type="pmid">16960178</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopman</surname><given-names>R.</given-names></name><name><surname>Wagenmakers</surname><given-names>A. J.</given-names></name><name><surname>Manders</surname><given-names>R. J.</given-names></name><name><surname>Zorenc</surname><given-names>A. H.</given-names></name><name><surname>Senden</surname><given-names>J. M.</given-names></name><name><surname>Gorselink</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis <italic>in vivo</italic> in male subjects</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source>
<volume>288</volume>, <fpage>E645</fpage>–<lpage>E653</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00413.2004</pub-id><pub-id pub-id-type="pmid">15562251</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>L.</given-names></name><name><surname>Fry</surname><given-names>A.</given-names></name></person-group> (<year>1995</year>). <article-title>Physiological assessment of physical fitness</article-title>, in <source>Strength Testing: Development and Evalution of Methodology</source>, eds <person-group person-group-type="editor"><name><surname>Maud</surname><given-names>P.</given-names></name><name><surname>Foster</surname><given-names>C.</given-names></name></person-group> (<publisher-loc>Leeds</publisher-loc>: <publisher-name>Human Kinetics</publisher-name>), <fpage>115</fpage>–<lpage>133</lpage>.</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louard</surname><given-names>R. J.</given-names></name><name><surname>Barrett</surname><given-names>E. J.</given-names></name><name><surname>Gelfand</surname><given-names>R. A.</given-names></name></person-group> (<year>1990</year>). <article-title>Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man</article-title>. <source>Clin. Sci.</source>
<volume>79</volume>, <fpage>457</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1042/cs0790457</pub-id><pub-id pub-id-type="pmid">2174312</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macnaughton</surname><given-names>L. S.</given-names></name><name><surname>Wardle</surname><given-names>S. L.</given-names></name><name><surname>Witard</surname><given-names>O. C.</given-names></name><name><surname>McGlory</surname><given-names>C.</given-names></name><name><surname>Hamilton</surname><given-names>D. L.</given-names></name><name><surname>Jeromson</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>The response of muscle protein synthesis following whole-body resistance exercise is greater following 40 g than 20 g of ingested whey protein</article-title>. <source>Physiol. Rep.</source>
<volume>4</volume>:<fpage>e12893</fpage>. <pub-id pub-id-type="doi">10.14814/phy2.12893</pub-id><pub-id pub-id-type="pmid">27511985</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>D. E.</given-names></name></person-group> (<year>2005</year>). <article-title>Observations of branched-chain amino acid administration in humans</article-title>. <source>J. Nutr.</source>
<volume>135</volume>, <fpage>1580S</fpage>–<lpage>1584S</lpage>. <pub-id pub-id-type="pmid">15930473</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayhew</surname><given-names>J. L.</given-names></name><name><surname>Prinster</surname><given-names>J. L.</given-names></name><name><surname>Ware</surname><given-names>J. S.</given-names></name><name><surname>Zimmer</surname><given-names>D. L.</given-names></name><name><surname>Arabas</surname><given-names>J. R.</given-names></name><name><surname>Bemben</surname><given-names>M. G.</given-names></name></person-group> (<year>1995</year>). <article-title>Muscular endurance repetitions to predict bench press strength in men of different training levels</article-title>. <source>J. Sports Med. Phys. Fitness</source>
<volume>35</volume>, <fpage>108</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="pmid">7500624</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGlory</surname><given-names>C.</given-names></name><name><surname>Wardle</surname><given-names>S. L.</given-names></name><name><surname>Macnaughton</surname><given-names>L. S.</given-names></name><name><surname>Witard</surname><given-names>O. C.</given-names></name><name><surname>Scott</surname><given-names>F.</given-names></name><name><surname>Dick</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Fish oil supplementation suppresses resistance exercise and feeding-induced increases in anabolic signaling without affecting myofibrillar protein synthesis in young men</article-title>. <source>Physiol. Rep.</source>
<volume>4</volume>:<fpage>e12715</fpage>. <pub-id pub-id-type="doi">10.14814/phy2.12715</pub-id><pub-id pub-id-type="pmid">27009278</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moberg</surname><given-names>M.</given-names></name><name><surname>Apro</surname><given-names>W.</given-names></name><name><surname>Ekblom</surname><given-names>B.</given-names></name><name><surname>Van Hall</surname><given-names>G.</given-names></name><name><surname>Holmberg</surname><given-names>H. C.</given-names></name><name><surname>Blomstrand</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Activation of mTORC1 by leucine is potentiated by branched-chain amino acids and even more so by essential amino acids following resistance exercise</article-title>. <source>Am. J. Physiol. Cell Physiol.</source>
<volume>310</volume>, <fpage>C874</fpage>–<lpage>C884</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00374.2015</pub-id><pub-id pub-id-type="pmid">27053525</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moberg</surname><given-names>M.</given-names></name><name><surname>Apro</surname><given-names>W.</given-names></name><name><surname>Ohlsson</surname><given-names>I.</given-names></name><name><surname>Ponten</surname><given-names>M.</given-names></name><name><surname>Villanueva</surname><given-names>A.</given-names></name><name><surname>Ekblom</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Absence of leucine in an essential amino acid supplement reduces activation of mTORC1 signalling following resistance exercise in young females</article-title>. <source>Appl. Physiol. Nutr. Metab</source>. <volume>39</volume>, <fpage>183</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1139/apnm-2013-0244</pub-id><pub-id pub-id-type="pmid">24476474</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>D. R.</given-names></name><name><surname>Tang</surname><given-names>J. E.</given-names></name><name><surname>Burd</surname><given-names>N. A.</given-names></name><name><surname>Rerecich</surname><given-names>T.</given-names></name><name><surname>Tarnopolsky</surname><given-names>M. A.</given-names></name><name><surname>Phillips</surname><given-names>S. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Differential stimulation of myofibrillar and sarcoplasmic protein synthesis with protein ingestion at rest and after resistance exercise</article-title>. <source>J. Physiol.</source>
<volume>587</volume>, <fpage>897</fpage>–<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2008.164087</pub-id><pub-id pub-id-type="pmid">19124543</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>K. S.</given-names></name><name><surname>Matthews</surname><given-names>D. E.</given-names></name><name><surname>Welle</surname><given-names>S. L.</given-names></name><name><surname>Braiman</surname><given-names>T.</given-names></name></person-group> (<year>1992</year>). <article-title>Effect of leucine on amino acid and glucose metabolism in humans</article-title>. <source>Metab. Clin. Exp.</source>
<volume>41</volume>, <fpage>643</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/0026-0495(92)90057-H</pub-id><pub-id pub-id-type="pmid">1640850</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname><given-names>L. E.</given-names></name><name><surname>Wilson</surname><given-names>G. J.</given-names></name><name><surname>Layman</surname><given-names>D. K.</given-names></name><name><surname>Moulton</surname><given-names>C. J.</given-names></name><name><surname>Garlick</surname><given-names>P. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Leucine content of dietary proteins is a determinant of postprandial skeletal muscle protein synthesis in adult rats</article-title>. <source>Nutr. Metab.</source>
<volume>9</volume>:<fpage>67</fpage>. <pub-id pub-id-type="doi">10.1186/1743-7075-9-67</pub-id><pub-id pub-id-type="pmid">22818257</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennings</surname><given-names>B.</given-names></name><name><surname>Koopman</surname><given-names>R.</given-names></name><name><surname>Beelen</surname><given-names>M.</given-names></name><name><surname>Senden</surname><given-names>J. M.</given-names></name><name><surname>Saris</surname><given-names>W. H.</given-names></name><name><surname>Van Loon</surname><given-names>L. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Exercising before protein intake allows for greater use of dietary protein-derived amino acids for de novo muscle protein synthesis in both young and elderly men</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>93</volume>, <fpage>322</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.2010.29649</pub-id><pub-id pub-id-type="pmid">21084649</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philp</surname><given-names>A.</given-names></name><name><surname>Hamilton</surname><given-names>D. L.</given-names></name><name><surname>Baar</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1</article-title>. <source>J Appl. Physiol. (1985)</source>
<volume>110</volume>, <fpage>561</fpage>–<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00941.2010</pub-id><pub-id pub-id-type="pmid">21071597</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K.</given-names></name><name><surname>Reynolds</surname><given-names>N.</given-names></name><name><surname>Downie</surname><given-names>S.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Rennie</surname><given-names>M. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Effects of flooding amino acids on incorporation of labeled amino acids into human muscle protein</article-title>. <source>Am. J. Physiol.</source>
<volume>275</volume>, <fpage>E73</fpage>–<lpage>E78</lpage>. <pub-id pub-id-type="pmid">9688876</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>G. N.</given-names></name><name><surname>Pacy</surname><given-names>P. J.</given-names></name><name><surname>Merritt</surname><given-names>H.</given-names></name><name><surname>Ford</surname><given-names>G. C.</given-names></name><name><surname>Read</surname><given-names>M. A.</given-names></name><name><surname>Cheng</surname><given-names>K. N.</given-names></name><etal></etal></person-group>. (<year>1989</year>). <article-title>Rapid measurement of whole body and forearm protein turnover using a [2H5]phenylalanine model</article-title>. <source>Am. J. Physiol.</source>
<volume>256</volume>, <fpage>E631</fpage>–<lpage>E639</lpage>. <pub-id pub-id-type="pmid">2719103</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tipton</surname><given-names>K. D.</given-names></name><name><surname>Elliott</surname><given-names>T. A.</given-names></name><name><surname>Ferrando</surname><given-names>A. A.</given-names></name><name><surname>Aarsland</surname><given-names>A. A.</given-names></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Stimulation of muscle anabolism by resistance exercise and ingestion of leucine plus protein</article-title>. <source>Appl. Physiol. Nutr. Metab.</source>
<volume>34</volume>, <fpage>151</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1139/H09-006</pub-id><pub-id pub-id-type="pmid">19370045</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tipton</surname><given-names>K. D.</given-names></name><name><surname>Ferrando</surname><given-names>A. A.</given-names></name><name><surname>Phillips</surname><given-names>S. M.</given-names></name><name><surname>Doyle</surname><given-names>D.</given-names><suffix>Jr.</suffix></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name></person-group> (<year>1999a</year>). <article-title>Postexercise net protein synthesis in human muscle from orally administered amino acids</article-title>. <source>Am. J. Physiol.</source>
<volume>276</volume>, <fpage>E628</fpage>–<lpage>E634</lpage>. <pub-id pub-id-type="pmid">10198297</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tipton</surname><given-names>K. D.</given-names></name><name><surname>Ferrando</surname><given-names>A. A.</given-names></name><name><surname>Williams</surname><given-names>B. D.</given-names></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name></person-group> (<year>1996</year>). <article-title>Muscle protein metabolism in female swimmers after a combination of resistance and endurance exercise</article-title>. <source>J. Appl. Physiol. (1985)</source>
<volume>81</volume>, <fpage>2034</fpage>–<lpage>2038</lpage>. <pub-id pub-id-type="pmid">8941526</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tipton</surname><given-names>K. D.</given-names></name><name><surname>Gurkin</surname><given-names>B. E.</given-names></name><name><surname>Matin</surname><given-names>S.</given-names></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name></person-group> (<year>1999b</year>). <article-title>Nonessential amino acids are not necessary to stimulate net muscle protein synthesis in healthy volunteers</article-title>. <source>J. Nutr. Biochem.</source>
<volume>10</volume>, <fpage>89</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/S0955-2863(98)00087-4</pub-id><pub-id pub-id-type="pmid">15539275</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tipton</surname><given-names>K. D.</given-names></name><name><surname>Rasmussen</surname><given-names>B. B.</given-names></name><name><surname>Miller</surname><given-names>S. L.</given-names></name><name><surname>Wolf</surname><given-names>S. E.</given-names></name><name><surname>Owens-Stovall</surname><given-names>S. K.</given-names></name><name><surname>Petrini</surname><given-names>B. E.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source>
<volume>281</volume>, <fpage>E197</fpage>–<lpage>E206</lpage>. <pub-id pub-id-type="pmid">11440894</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdijk</surname><given-names>L. B.</given-names></name><name><surname>Van Loon</surname><given-names>L.</given-names></name><name><surname>Meijer</surname><given-names>K.</given-names></name><name><surname>Savelberg</surname><given-names>H. H.</given-names></name></person-group> (<year>2009</year>). <article-title>One-repetition maximum strength test represents a valid means to assess leg strength <italic>in vivo</italic> in humans</article-title>. <source>J. Sports Sci.</source>
<volume>27</volume>, <fpage>59</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1080/02640410802428089</pub-id><pub-id pub-id-type="pmid">19031334</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>B. T.</given-names></name><name><surname>Hamer</surname><given-names>H. M.</given-names></name><name><surname>De Lange</surname><given-names>A.</given-names></name><name><surname>Kiskini</surname><given-names>A.</given-names></name><name><surname>Groen</surname><given-names>B. B.</given-names></name><name><surname>Senden</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Leucine co-ingestion improves post-prandial muscle protein accretion in elderly men</article-title>. <source>Clin. Nutr.</source>
<volume>32</volume>, <fpage>412</fpage>–<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2012.09.002</pub-id><pub-id pub-id-type="pmid">23043721</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>D. J.</given-names></name><name><surname>Hossain</surname><given-names>T.</given-names></name><name><surname>Hill</surname><given-names>D. S.</given-names></name><name><surname>Phillips</surname><given-names>B. E.</given-names></name><name><surname>Crossland</surname><given-names>H.</given-names></name><name><surname>Williams</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Effects of leucine and its metabolite β-hydroxy-β-methylbutyrate on human skeletal muscle protein metabolism</article-title>. <source>J. Physiol.</source>
<volume>591</volume>, <fpage>2911</fpage>–<lpage>2923</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2013.253203</pub-id><pub-id pub-id-type="pmid">23551944</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witard</surname><given-names>O. C.</given-names></name><name><surname>Jackman</surname><given-names>S. R.</given-names></name><name><surname>Breen</surname><given-names>L.</given-names></name><name><surname>Smith</surname><given-names>K.</given-names></name><name><surname>Selby</surname><given-names>A.</given-names></name><name><surname>Tipton</surname><given-names>K. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Myofibrillar muscle protein synthesis rates subsequent to a meal in response to increasing doses of whey protein at rest and after resistance exercise</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>99</volume>, <fpage>86</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.112.055517</pub-id><pub-id pub-id-type="pmid">24257722</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witard</surname><given-names>O. C.</given-names></name><name><surname>Tieland</surname><given-names>M.</given-names></name><name><surname>Beelen</surname><given-names>M.</given-names></name><name><surname>Tipton</surname><given-names>K. D.</given-names></name><name><surname>Van Loon</surname><given-names>L. J.</given-names></name><name><surname>Koopman</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Resistance exercise increases postprandial muscle protein synthesis in humans</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>41</volume>, <fpage>144</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0b013e3181844e79</pub-id><pub-id pub-id-type="pmid">19092695</pub-id></mixed-citation></ref></ref-list></back></article>